JPS6012324B2 - Vasodilators and antihypertensive agents containing 1,4-dihydropyridine derivatives - Google Patents
Vasodilators and antihypertensive agents containing 1,4-dihydropyridine derivativesInfo
- Publication number
- JPS6012324B2 JPS6012324B2 JP59091231A JP9123184A JPS6012324B2 JP S6012324 B2 JPS6012324 B2 JP S6012324B2 JP 59091231 A JP59091231 A JP 59091231A JP 9123184 A JP9123184 A JP 9123184A JP S6012324 B2 JPS6012324 B2 JP S6012324B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydropyridine
- acid
- ester
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title claims description 6
- 239000002220 antihypertensive agent Substances 0.000 title claims description 3
- 229940030600 antihypertensive agent Drugs 0.000 title claims description 3
- 229940124549 vasodilator Drugs 0.000 title claims description 3
- 239000003071 vasodilator agent Substances 0.000 title claims description 3
- 239000000126 substance Substances 0.000 claims description 46
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000004423 acyloxy group Chemical group 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000000676 alkoxyimino group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 201
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 167
- 239000000243 solution Substances 0.000 description 116
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 114
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 104
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 101
- 239000000203 mixture Substances 0.000 description 78
- -1 neobentyl Chemical group 0.000 description 74
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 72
- 239000013078 crystal Substances 0.000 description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 63
- 239000002904 solvent Substances 0.000 description 57
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 50
- 238000006243 chemical reaction Methods 0.000 description 49
- 150000001875 compounds Chemical class 0.000 description 48
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 39
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
- 239000002253 acid Substances 0.000 description 36
- 239000000284 extract Substances 0.000 description 34
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- 239000000843 powder Substances 0.000 description 30
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 28
- 238000000862 absorption spectrum Methods 0.000 description 27
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 26
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
- 235000019341 magnesium sulphate Nutrition 0.000 description 25
- 125000004494 ethyl ester group Chemical group 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 22
- 238000010898 silica gel chromatography Methods 0.000 description 21
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- 238000010992 reflux Methods 0.000 description 19
- 239000011780 sodium chloride Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 13
- 238000005481 NMR spectroscopy Methods 0.000 description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
- 235000017557 sodium bicarbonate Nutrition 0.000 description 13
- 238000005406 washing Methods 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 239000012156 elution solvent Substances 0.000 description 12
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 239000001632 sodium acetate Substances 0.000 description 10
- 235000017281 sodium acetate Nutrition 0.000 description 10
- 238000006297 dehydration reaction Methods 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 229910000033 sodium borohydride Inorganic materials 0.000 description 9
- 239000012279 sodium borohydride Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 101150041968 CDC13 gene Proteins 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 125000001589 carboacyl group Chemical group 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- YPMPTULBFPFSEQ-PLNGDYQASA-N ethyl (z)-3-aminobut-2-enoate Chemical compound CCOC(=O)\C=C(\C)N YPMPTULBFPFSEQ-PLNGDYQASA-N 0.000 description 6
- 125000004043 oxo group Chemical group O=* 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 5
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000001241 acetals Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000012024 dehydrating agents Substances 0.000 description 4
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- MBELGTLJWJJGLF-UHFFFAOYSA-N 1,4-dihydropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CNC=CC1 MBELGTLJWJJGLF-UHFFFAOYSA-N 0.000 description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- WQGDVCSIAAMRAD-UHFFFAOYSA-N 2-[(2-nitrophenyl)methylidene]-3-oxobutanoic acid Chemical compound CC(=O)C(C(O)=O)=CC1=CC=CC=C1[N+]([O-])=O WQGDVCSIAAMRAD-UHFFFAOYSA-N 0.000 description 2
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 2
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 2
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- LCNQMPRQBNCYHG-UHFFFAOYSA-N diethyl 1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=CNC=C(C(=O)OCC)C1 LCNQMPRQBNCYHG-UHFFFAOYSA-N 0.000 description 2
- GEQMKOUBYYFIIK-UHFFFAOYSA-N diethyl 2-(diethoxymethyl)-6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C(OCC)OCC)=C(C(=O)OCC)C1C1=CC=CC=C1[N+]([O-])=O GEQMKOUBYYFIIK-UHFFFAOYSA-N 0.000 description 2
- NXTDCMWVPRPUBC-UHFFFAOYSA-N diethyl 4-(2-chlorophenyl)-2-formyl-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C=O)=C(C(=O)OCC)C1C1=CC=CC=C1Cl NXTDCMWVPRPUBC-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 238000010575 fractional recrystallization Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 description 1
- MTXDVXJXKQJRHR-UHFFFAOYSA-N (6-chlorobenzotriazol-1-yl) 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)ON1C2=CC(Cl)=CC=C2N=N1 MTXDVXJXKQJRHR-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- VFVHWCKUHAEDMY-UHFFFAOYSA-N 2-chloro-5-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(C=O)=C1 VFVHWCKUHAEDMY-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- DFUFMHWUYAETKD-UHFFFAOYSA-N 3-[benzyl(methyl)amino]propanoyl chloride Chemical compound ClC(=O)CCN(C)CC1=CC=CC=C1 DFUFMHWUYAETKD-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- QUEHTJCHIQKEIB-UHFFFAOYSA-N 5-ethoxycarbonyl-6-(hydroxymethyl)-2-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid Chemical compound CCOC(=O)C1=C(CO)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 QUEHTJCHIQKEIB-UHFFFAOYSA-N 0.000 description 1
- XRFJQYBODMXBTI-UHFFFAOYSA-N 6-(diethoxymethyl)-5-ethoxycarbonyl-2-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid Chemical compound OC(=O)C1=C(C)NC(C(OCC)OCC)=C(C(=O)OCC)C1C1=CC=CC([N+]([O-])=O)=C1 XRFJQYBODMXBTI-UHFFFAOYSA-N 0.000 description 1
- SDDHMAGTNAWSJW-UHFFFAOYSA-N 6-cyano-5-ethoxycarbonyl-2-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid Chemical compound CCOC(=O)C1=C(C#N)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 SDDHMAGTNAWSJW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 1
- UIOAQJNADLELPQ-UHFFFAOYSA-N C[C]1OCCO1 Chemical group C[C]1OCCO1 UIOAQJNADLELPQ-UHFFFAOYSA-N 0.000 description 1
- 101100537937 Caenorhabditis elegans arc-1 gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- QPGWLKQGHLHETJ-UHFFFAOYSA-N [ethoxy(hydroxy)phosphoryl] phosphono hydrogen phosphate Chemical compound CCOP(O)(=O)OP(O)(=O)OP(O)(O)=O QPGWLKQGHLHETJ-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940090012 bentyl Drugs 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 125000004983 dialkoxyalkyl group Chemical group 0.000 description 1
- GUBNMFJOJGDCEL-UHFFFAOYSA-N dicyclomine hydrochloride Chemical group [Cl-].C1CCCCC1C1(C(=O)OCC[NH+](CC)CC)CCCCC1 GUBNMFJOJGDCEL-UHFFFAOYSA-N 0.000 description 1
- ZMPJLUJGNJLQPX-UHFFFAOYSA-N diethyl 2-(acetyloxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(COC(C)=O)=C(C(=O)OCC)C1C1=CC=CC([N+]([O-])=O)=C1 ZMPJLUJGNJLQPX-UHFFFAOYSA-N 0.000 description 1
- SGXNWGTXAZZVRP-UHFFFAOYSA-N diethyl 2-(diethoxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C(OCC)OCC)=C(C(=O)OCC)C1C1=CC=CC([N+]([O-])=O)=C1 SGXNWGTXAZZVRP-UHFFFAOYSA-N 0.000 description 1
- GXKSWXZFULNTIZ-UHFFFAOYSA-N diethyl 2-(diethoxymethyl)-6-methyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C(OCC)OCC)=C(C(=O)OCC)C1C1=CC=CC=C1C(F)(F)F GXKSWXZFULNTIZ-UHFFFAOYSA-N 0.000 description 1
- SRZSFBGSBTWTEB-UHFFFAOYSA-N diethyl 2-(hydroxymethyl)-6-methyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(CO)=C(C(=O)OCC)C1C1=CC=CC=C1C(F)(F)F SRZSFBGSBTWTEB-UHFFFAOYSA-N 0.000 description 1
- QUJMAJRCHXBYPY-UHFFFAOYSA-N diethyl 4-(2-chlorophenyl)-2-(hydroxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(CO)=C(C(=O)OCC)C1C1=CC=CC=C1Cl QUJMAJRCHXBYPY-UHFFFAOYSA-N 0.000 description 1
- YUYOLDHKWAOOBO-UHFFFAOYSA-N diethyl 6,8-dimethyl-8-(2-nitrophenyl)-2,3-dihydropyrido[1,2-b][1,4,2]dioxazine-7,9-dicarboxylate Chemical compound CCOC(=O)C1=C(C)N2OCCOC2=C(C(=O)OCC)C1(C)C1=CC=CC=C1[N+]([O-])=O YUYOLDHKWAOOBO-UHFFFAOYSA-N 0.000 description 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- XVENMMSPXHZGBV-UHFFFAOYSA-N dimethyl 4-(2-chlorophenyl)-2-(1-hydroxyethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C(C)O)=C(C(=O)OC)C1C1=CC=CC=C1Cl XVENMMSPXHZGBV-UHFFFAOYSA-N 0.000 description 1
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- YGFPTOGFJZRWJR-FPLPWBNLSA-N ethyl (z)-3-amino-4,4-diethoxybut-2-enoate Chemical compound CCOC(OCC)C(\N)=C\C(=O)OCC YGFPTOGFJZRWJR-FPLPWBNLSA-N 0.000 description 1
- OZSLMVAWLCQORW-UHFFFAOYSA-N ethyl 4,4-diethoxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methylidene]butanoate Chemical compound CCOC(OCC)C(=O)C(C(=O)OCC)=CC1=CC=CC=C1C(F)(F)F OZSLMVAWLCQORW-UHFFFAOYSA-N 0.000 description 1
- HYVRRAANXHHPGH-UHFFFAOYSA-N ethyl 4,4-diethoxy-3-oxobutanoate Chemical compound CCOC(OCC)C(=O)CC(=O)OCC HYVRRAANXHHPGH-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- WMYNMYVRWWCRPS-UHFFFAOYSA-N ethynoxyethane Chemical group CCOC#C WMYNMYVRWWCRPS-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- SPUACDWLOLSOQO-UHFFFAOYSA-M methoxyazanium;chloride Chemical compound [Cl-].CO[NH3+] SPUACDWLOLSOQO-UHFFFAOYSA-M 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- XKORCTIIRYKLLG-ARJAWSKDSA-N methyl (z)-3-aminobut-2-enoate Chemical compound COC(=O)\C=C(\C)N XKORCTIIRYKLLG-ARJAWSKDSA-N 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- PVFOMCVHYWHZJE-UHFFFAOYSA-N trichloroacetyl chloride Chemical compound ClC(=O)C(Cl)(Cl)Cl PVFOMCVHYWHZJE-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
この発明は血管拡張作用および血圧下降作用を有し、医
薬として有用である新規な1・4−ジヒドロピリジン誘
導体を含有する血管拡張剤および血圧降下剤に関するも
のである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a vasodilator and antihypertensive agent containing a novel 1,4-dihydropyridine derivative that has vasodilating and hypotensive effects and is useful as a pharmaceutical.
この発明で使用される1・4ージヒドロピリジン誘導体
は一般式(式中、R,は置換基としてハロゲン、ニトロ
、トリフルオロメチルおよびアルケニルオキシからなる
群から選ばれた基を有するフェニル基を、R2およびR
3は同一または異なるアルコキシカルボニル基、アルコ
キシアルコキシカルボニル基、アラルコキシアルコキシ
カルボニル基またはNーアルキルーNーアラルキルアミ
ノアルコキシカルボニル基を、R4はシアノ基またはヒ
ドロキシ、非置換低級アルカノィルオキシ、低級アルコ
キシィミノ、オキソ、Nーアルキル−N−アラルキルア
ミノ低級アルカノィルオキシもしくはモノハロアリール
オキシ低級ァルカノイルオキシで置換されたアルキル基
を、R5はアルキル基をそれぞれ意味する)で示される
。The 1,4-dihydropyridine derivative used in this invention has the general formula (wherein R is a phenyl group having a group selected from the group consisting of halogen, nitro, trifluoromethyl and alkenyloxy as a substituent, R2 and R
3 is the same or different alkoxycarbonyl group, alkoxyalkoxycarbonyl group, aralkoxyalkoxycarbonyl group or N-alkyl-N-aralkyl aminoalkoxycarbonyl group, R4 is a cyano group or hydroxy, unsubstituted lower alkanoyloxy, lower alkoxy an alkyl group substituted with mino, oxo, N-alkyl-N-aralkylamino lower alkanoyloxy or monohaloaryloxy lower alkanoyloxy; R5 means an alkyl group, respectively);
この明細書の前記一般式(1)ならびに後記の他の一般
式および反応誌剤等の定義において用いられている用語
を説明すると次の通りである。The terms used in the definitions of the general formula (1) and other general formulas and reaction agents described later in this specification are as follows.
ハロゲンおよび他の置換基中に含まれるハロ部分とはふ
つ素、塩素、臭素、よう秦等のハロゲン原子を意味する
。アルキル基および他の置換基に含まれるアルキル部分
とは直鎖または分枝鎖状の1価の飽和炭化水素基であっ
て、好ましくはメチル、エチル、ブロピル、イソプロピ
ル、ブチル、イソプチル、t−ブチル、ベンチル、ネオ
ベンチル、ヘキシル、へプチル、オクチル等の低級アル
キル基を意味する。Halogen and the halo moiety contained in other substituents refer to halogen atoms such as fluorine, chlorine, bromine, and bromine. The alkyl group and the alkyl moiety contained in other substituents are linear or branched monovalent saturated hydrocarbon groups, preferably methyl, ethyl, propyl, isopropyl, butyl, isobutyl, and t-butyl. , refers to a lower alkyl group such as bentyl, neobentyl, hexyl, heptyl, octyl, etc.
アルコキシ基または他の置換基中に含まれるアルコキシ
部分は「好ましくはメトキシ、ェトキシ、プロボキシ、
イソプロポキシ、プトキシ、t−ブトキシ、ベントキシ
等の低級アルコキシ基を意味する。The alkoxy moiety contained in the alkoxy group or other substituents is preferably methoxy, ethoxy, propoxy,
It means a lower alkoxy group such as isopropoxy, putoxy, t-butoxy, bentoxy.
アルケニルとは直鎖または分枝鎖状の1以上の二重結合
を有する1価の不飽和炭化水素基であって、好ましくは
ビニル、アリル、1−プロベニル、3ーブテニル、1・
3ープタジエニル、2・4ーベンタジェニル等の低級ア
ルケニル茎を意味する。Alkenyl is a linear or branched monovalent unsaturated hydrocarbon group having one or more double bonds, preferably vinyl, allyl, 1-probenyl, 3-butenyl, 1.
It means lower alkenyl stems such as 3-ptadienyl and 2,4-bentadienyl.
非置換低級アルカノイル基の好ましい例としては、ホル
ミル、アセチル、プロピオニル、プチリル、イソブチリ
ル、バレリル、イソバレリル、ピバロィル等が挙げられ
る。Preferred examples of unsubstituted lower alkanoyl groups include formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl, and the like.
Nーアルキル−Nーアラルキルアミノアルカノイルとし
ては2(または3)−(N−メチル−Nーベンジルアミ
ノ)プロピオニル等が挙げられる。Examples of N-alkyl-N-aralkyl aminoalkanoyl include 2(or 3)-(N-methyl-N-benzylamino)propionyl and the like.
モノハロアリールオキシアルカノィルの好ましい例とし
ては2(または3または4)ークロロフエノキシアセチ
ル、2(または3)一〔2(または3または4)ークロ
ロフエノキシ〕プロピオニル等が挙げられる。Preferred examples of monohaloaryloxyalkanoyl include 2(or 3 or 4)-chlorophenoxyacetyl, 2(or 3)-[2(or 3 or 4)-chlorophenoxy]propionyl, and the like.
アルコキシカルポニル基としては例えばメトキシカルボ
ニル、エトキシカルポニル、プ。Examples of the alkoxycarbonyl group include methoxycarbonyl, ethoxycarbonyl, and carbonyl.
ポキシカルボニル、ブトキシカルボニル、tーブトキシ
カルボニル等が挙げられる。アルコキシアルコキシカル
ボニル基としては2ーメトキシエトキシカルボニル、2
−エトキシエトキシカルポニル、2(または3)ーメト
キシ(またはェトキシ)プロポキシカルボニル等が挙げ
られる。Examples include poxycarbonyl, butoxycarbonyl, t-butoxycarbonyl, and the like. As the alkoxyalkoxycarbonyl group, 2-methoxyethoxycarbonyl, 2
-ethoxyethoxycarbonyl, 2(or 3)-methoxy(or ethoxy)propoxycarbonyl, and the like.
アラルコキシアルコキシカルボニル基としては2−(ベ
ンジルオキシ)ヱトキシカルポニル、2(または3)ー
ベンジルオキシプロポキシカルボニル等が挙げられる。Examples of the aralkoxyalkoxycarbonyl group include 2-(benzyloxy)ethoxycarbonyl and 2(or 3)-benzyloxypropoxycarbonyl.
N−アルキル−Nーアラルキルアミノアルコキシカルポ
ニル基の好ましい例としては2一(N−メチル−N−ペ
ンジルアミノ)エトキシカルポニル等が挙げられる。オ
キソで置換されたアルキル基とは、ァルカノィル基、好
ましくはホルミル、アセチル、プロピオニル、ブチリル
、イソプチリル、バレリル、イソバレリル、ピバロィル
等の低級アルカノィル基またはアルカノィルアルキル基
、好ましくはホルミルメチル、アセトニル、2−ホルミ
ルエチル、3−ホルミルプロピル、ブチリルメチル等の
低級アルカノィル置換低級アルキル基を意味する。Preferred examples of the N-alkyl-N-aralkyl aminoalkoxycarponyl group include 2-(N-methyl-N-pendylamino)ethoxycarponyl. The oxo-substituted alkyl group refers to an alkanoyl group, preferably a lower alkanoyl group or an alkanoyl alkyl group such as formyl, acetyl, propionyl, butyryl, isoptyryl, valeryl, isovaleryl, pivaloyl, etc., preferably formylmethyl, acetonyl, 2 - Means a lower alkyl group substituted with lower alkanoyl such as formylethyl, 3-formylpropyl, butyrylmethyl.
アセタールとされているオキソで置換されたアルキル基
としては上記のアルカノイル基およびアルカノィルアル
キル基におけるカルボニル基がアセ夕−ルとして保護さ
れているものであり、このようなアセタールとして保護
されたカルボニル基を有するアルカノイル基およびアル
カノィルアルキル基の例としては、袋mージアルコキシ
アルキル基、好ましくはジメトキシメチル、1・1ージ
メトキシエチル、ジエトキシメチル、ジプロボキシメチ
ル、202ージエトキシエチル、2・2ージェトキシプ
ロピル等の袋mージ低級アルコキシ置換低級アルキル基
、蟹m−ァルキレンジオキシアルキル基、好ましくは1
・3ージオキソランー2ーイル、2−メチル一1・3ー
ジオキソランー2ーイル、4−メチル−1・3−ジオキ
ソラン−2ーイル、4・5−ジメチル−1・3ージオキ
ソランー2−イル、1・3ージオキサン−2ーイル、2
ーメチルー1・3−ジオキサン−2−イル、1・3−ジ
オキソランー2ーイルメチル、2ーメチルー1・3ージ
オキソランー2ーイルメチル、3−(1・3−ジオキソ
ランー2−イル)プロピル等の袋m−低級アルキレンジ
オキシ置換低級アルキル基等の鎖状または環状のアセタ
ール・タイプのものが例示される。この発明で使用され
る化合物(1)は次に示す方法により製造される。The oxo-substituted alkyl group that is considered to be an acetal is one in which the carbonyl group in the above alkanoyl group and alkanoyl alkyl group is protected as an acetal. Examples of alkanoyl groups and alkanoylalkyl groups having groups include dialkoxyalkyl groups, preferably dimethoxymethyl, 1,1-dimethoxyethyl, diethoxymethyl, diproboxymethyl, 202-diethoxyethyl. , 2-di-lower alkoxy-substituted lower alkyl groups such as 2-jethoxypropyl, m-alkylenedioxyalkyl groups, preferably 1
・3-dioxolan-2-yl, 2-methyl-1,3-dioxolan-2-yl, 4-methyl-1,3-dioxolan-2-yl, 4,5-dimethyl-1,3-dioxolan-2-yl, 1,3-dioxan-2 -il, 2
-M-lower alkylenedioxy such as methyl-1,3-dioxan-2-yl, 1,3-dioxolan-2-ylmethyl, 2-methyl-1,3-dioxolan-2-ylmethyl, 3-(1,3-dioxolan-2-yl)propyl, etc. Examples include chain or cyclic acetal types such as substituted lower alkyl groups. Compound (1) used in this invention is produced by the method shown below.
1 カルボニル基における保護基の加水分解による脱離
:化合物(1)のうち、一般式
(式中、R,、R2、R3およびR5は前と同じ意味で
あり、R4bはオキソで置換されたァルキル基を意味す
る)で示される化合物は、一般式
(式中、R,、R2、R3およびR5は前と同じ意味で
あり、R畿はアセタールとして保護されているオキソ置
換されたアルキル基を意味する)で示される化合物を加
水分解することにより製造することができる。1. Elimination by hydrolysis of the protecting group in the carbonyl group: Among compound (1), the general formula (wherein R,, R2, R3 and R5 have the same meanings as before, and R4b is The compound represented by the general formula (where R, , R2, R3 and R5 have the same meanings as before, and R represents an oxo-substituted alkyl group protected as an acetal) It can be produced by hydrolyzing the compound shown in ).
原料化合物(1−1)は下記実施例に記載した方法また
はそれらと同様の方法で製造できる。Raw material compound (1-1) can be produced by the method described in the following Examples or a method similar thereto.
化合物(1−1)におけるR41のアルキル基がオキソ
で置換されることにより形成されたカルボニル基上のア
セタールがこの加水分解によって脱離され、化合物(1
一2)が得られる。The acetal on the carbonyl group formed by substituting the alkyl group of R41 in compound (1-1) with oxo is eliminated by this hydrolysis, and compound (1)
12) is obtained.
この加水分解は通常酸性条件下、例えば塩酸、硫酸等の
無機酸または義酸、酢酸、トリフルオロ酢酸、pートル
ェンスルホン酸等の有機酸の存在下で行なわれる。This hydrolysis is usually carried out under acidic conditions, for example in the presence of an inorganic acid such as hydrochloric acid or sulfuric acid, or an organic acid such as acetic acid, acetic acid, trifluoroacetic acid or p-toluenesulfonic acid.
この加水分解反応は、通常溶媒中で行なわれ、溶媒とし
ては水、アセトン、メチルエチルケトン、ジオキサン、
メタノール、エタノール、N・N一ジメチルホルムアミ
ド、N−メチルモルホリン、これらの有機溶媒と水との
混合溶媒または通常の緩衝溶液等が挙げられる。This hydrolysis reaction is usually carried out in a solvent, such as water, acetone, methyl ethyl ketone, dioxane,
Examples include methanol, ethanol, N·N-dimethylformamide, N-methylmorpholine, mixed solvents of these organic solvents and water, or ordinary buffer solutions.
反応温度は特に限定されないが、通常冷却下、室温また
は加湿下で行なわれる。2 ィミノ基形成縮合反応:
化合物(1)のうち、−舟史式
(式中、R,、R2、R3およびR5は前と同じ意味で
あり、Rには低級アルコキシィミノで置換されたアルキ
ル基を意味する)で示される化合物は、前記の方法1で
製造された化合物(1−2)に、一般式R8−N比
(0)(式中、R8は低級アルコキ
シ基を意味する)で示されるアミン化合物を作用させる
ことにより製造することができる。The reaction temperature is not particularly limited, but it is usually carried out under cooling, room temperature, or humidification. 2 Imino group-forming condensation reaction: Of the compound (1), -Fumi formula (wherein R,, R2, R3 and R5 have the same meanings as before, R is an alkyl substituted with lower alkoxyimino) The compound represented by (representing a group) is the compound (1-2) produced by the above-mentioned method 1, which has the general formula R8-N ratio.
It can be produced by reacting with an amine compound represented by (0) (in the formula, R8 means a lower alkoxy group).
この縮合反応によって、出発化合物(1一2)における
R4bで示されるオキソで置換されたアルキル基のオキ
ソ基が式=N−R8(式中、R8は前と同じ意味)で示
されるイミノ基に置き換った化合物(1−3)が得られ
る。Through this condensation reaction, the oxo group of the oxo-substituted alkyl group represented by R4b in the starting compounds (1-2) becomes an imino group represented by the formula =N-R8 (wherein R8 has the same meaning as before). A substituted compound (1-3) is obtained.
この縮合反応は水、ジオキサン、メタノール、エタノー
ル、ジメチルホルムアミドまたはこれら有機溶媒と水と
の混合溶媒等の適当な溶媒中で行なわれ、通常酸性また
は塩基性条件下で反応が有利に進行するので、塩酸、臭
化水素酸、硫酸、義酸、酢酸、p−トルェンスルホン酸
、3ふつ化ほう素、4塩化けし、素、4塩化チタン等の
酸の存在下で、または塩基性緩衝液中で、あるいは過剰
のアミン化合物(0)を使用することによって反応を行
なうのが好ましい。This condensation reaction is carried out in a suitable solvent such as water, dioxane, methanol, ethanol, dimethylformamide, or a mixed solvent of these organic solvents and water, and the reaction usually proceeds advantageously under acidic or basic conditions. In the presence of an acid such as hydrochloric acid, hydrobromic acid, sulfuric acid, sulfuric acid, acetic acid, p-toluenesulfonic acid, boron trifluoride, poppy tetrachloride, titanium tetrachloride, or in a basic buffer. Preferably, the reaction is carried out with or by using an excess of amine compound (0).
反応温度は特に限定されないが、通常冷却下「室温、ま
たは加温下で行なわれる。この反応で用いられるアミン
化合物(0)としては○ーメチルヒドロキシアミン、0
−エチルヒドロキシアミン、0ープロピルヒドロキシア
ミン、0ーィソプロピルヒドロキシアミン等の低級フル
コキシアミンが挙げられる。The reaction temperature is not particularly limited, but it is usually carried out at room temperature under cooling, or under heating.The amine compound (0) used in this reaction is ○-methylhydroxyamine, 0
Examples include lower flukoxyamines such as -ethylhydroxyamine, 0-propylhydroxyamine, and 0-isopropylhydroxyamine.
このアミン化合物(ロ)は塩酸、硫酸等の無機酸または
酢酸等の有機酸等の酸との塩の形で使用することができ
る。3 脱水反応:
化合物(1)のうち、一般式
(式中、R,、R2、R3およびR5は前と同じ意味)
で示される化合物は、一般式(式中、R,、R2、R3
およびR5は前と同じ意味)で示される化合物に脱水剤
を作用させることにより製造することができる。This amine compound (b) can be used in the form of a salt with an acid such as an inorganic acid such as hydrochloric acid or sulfuric acid or an organic acid such as acetic acid. 3 Dehydration reaction: Among compound (1), the general formula (wherein R,, R2, R3 and R5 have the same meaning as before)
The compound represented by the general formula (wherein R,, R2, R3
and R5 have the same meanings as above) by reacting a dehydrating agent with the compound.
この脱水反応で用いられる原料化合物(1一3)は下記
実施例に記載した方法またはそれらと同様の方法で製造
される。The raw material compounds (1-3) used in this dehydration reaction are produced by the methods described in the following Examples or by methods similar thereto.
脱水反応に通常用いられる有機または無機の脱水剤はい
ずれもこの反応で脱水剤として使用することができ、そ
の好ましい例としては硫酸、りん酸トポリりん酸、義酸
、酢酸、ェタンスルホン酸、p−トルェンスルホン酸等
の酸;無水酢酸、無水安息香酸、無水フタル酸等の酸無
水物:酢酸クロラィド、安息香酸クロラィド、トリクロ
ロ酢酸クロラィド、メシルクロラィドもトシルクロラィ
ド、クロル炭酸エチル、クロル炭酸フェニル等の酸ハラ
ィド、チオニルクロライド、5塩化りん、オキシ塩化り
ん、3臭化りん、塩化第二錫、4塩化チタン等の無機ハ
ロゲン化化合物;N・N′−ジシクロヘキシルカルボジ
イド、N−シクロヘキシル−N′ーモルホリノェチルカ
ルボジィミド等のカルポジィミド化合物;N・N′−カ
ルポニルジィミダゾール、ベンタメチレンケテン−N−
シクロヘキシルイミン;エトキシアセチレン:2ーエチ
ル−7ーヒドロキシィソキサゾリウム塩;5酸化りん、
ポリりん酸エチルトリん酸エチル、りん酸フェニル等の
前記以外のりん酸化合物等が挙げられる。Any organic or inorganic dehydrating agent commonly used in dehydration reactions can be used as a dehydrating agent in this reaction, preferred examples of which are sulfuric acid, phosphoric acid, topolyphosphoric acid, diic acid, acetic acid, ethanesulfonic acid, p- Acids such as toluenesulfonic acid; acid anhydrides such as acetic anhydride, benzoic anhydride, and phthalic anhydride; acid halides such as acetic chloride, benzoic acid chloride, trichloroacetic acid chloride, mesyl chloride, tosyl chloride, ethyl chlorocarbonate, phenyl chlorocarbonate, etc. , thionyl chloride, phosphorus pentachloride, phosphorus oxychloride, phosphorus tribromide, stannic chloride, titanium tetrachloride, and other inorganic halogenated compounds; Carposimide compounds such as thylcarbodimide; N・N'-carponyldimidazole, bentamethyleneketene-N-
Cyclohexylimine; ethoxyacetylene: 2-ethyl-7-hydroxyisoxazolium salt; phosphorus pentoxide,
Examples include phosphoric acid compounds other than those listed above, such as ethyl polyphosphate and ethyl triphosphate, and phenyl phosphate.
また、この反応において、脱水剤として酸を用いる場合
、その酸のナトリウム、カリウム等の金属との塩の存在
下で行なうこともできる。この脱水反応はジェチルェー
テル、ジメチルホルムアミド、ピリジン、酢酸、菱酸、
ベンゼン、4塩化炭素、クロロホルム、塩化メチレン、
テトラヒドロフラン、ジオキサン等の溶媒中で行なわれ
る。In addition, when an acid is used as a dehydrating agent in this reaction, it can also be carried out in the presence of a salt of the acid with a metal such as sodium or potassium. This dehydration reaction involves the use of diethyl ether, dimethylformamide, pyridine, acetic acid, rhonic acid,
Benzene, carbon tetrachloride, chloroform, methylene chloride,
It is carried out in a solvent such as tetrahydrofuran or dioxane.
反応温度は特に限定されないが、通常室温または加温、
加熱下で反応が行なわれる。4 オキソの還元:
化合物(1)のうち、一般式
(式中、R,、R2、R3およびR5は前と同じ意味で
あり、Rぷまヒドロキシで置換されたアルキル基を意味
する)で示される化合物は、一般式
(式中、R,、R2、R3、R4bおよびR5は前と同
じ意味)で示される化合物を還元することによって製造
することができる。The reaction temperature is not particularly limited, but is usually room temperature or heating,
The reaction takes place under heat. 4 Reduction of oxo: Among compound (1), the compound represented by the general formula (wherein R,, R2, R3 and R5 have the same meanings as before and means an alkyl group substituted with R puma hydroxy) The compound can be produced by reducing a compound represented by the general formula (wherein R,, R2, R3, R4b and R5 have the same meanings as before).
還元方法としては、オキソ基をヒドロキシ基に還元する
ために通常用いられる方法はいずれも適用することがで
き、例えば、水素化ほう素リチウム、水素化ほう素ナト
リウム、水素化ほう素カリウム、水素化シアノほう素ナ
トリウム等の水素化ほう素アルカリ金属のような還元剤
を用いる還元、または接触還元等が挙げられる。As the reduction method, any method commonly used for reducing an oxo group to a hydroxy group can be applied, such as lithium borohydride, sodium borohydride, potassium borohydride, Examples include reduction using a reducing agent such as an alkali metal borohydride such as sodium cyanoborohydride, or catalytic reduction.
接触還元に用いる触媒としては、パラジウム炭素、塩化
パラジウム、ロジウム炭素等の他、通常接触還元に使用
される触媒はいずれも用いることができる。この反応は
通常、溶媒中で行なわれ、溶媒としては水、メタノール
、エタノール、インプロピルアルコール、ジメチルホル
ムアミド等この反応に悪影響を与えない溶媒はすべて使
用することができる。As the catalyst used for the catalytic reduction, in addition to palladium on carbon, palladium chloride, rhodium on carbon, etc., any catalyst normally used for the catalytic reduction can be used. This reaction is usually carried out in a solvent, and any solvent that does not adversely affect this reaction, such as water, methanol, ethanol, inpropyl alcohol, and dimethylformamide, can be used.
反応温度は特に限定されず、通常冷却下、室温、加温下
で反応が行なわれることが多い。還元方法は原料化合物
(1一2)の種類により適宜選択することができる。こ
の還元によって、出発化合物(1−2)のR′4bにお
けるオキソ部分が還元されて、ヒドロキシに変った化合
物(1−5)が得られる。The reaction temperature is not particularly limited, and the reaction is usually carried out under cooling, at room temperature, or under heating. The reduction method can be appropriately selected depending on the type of the raw material compounds (1-2). By this reduction, the oxo moiety in R'4b of the starting compound (1-2) is reduced, and a compound (1-5) in which it has been changed to hydroxy is obtained.
5 ヒドロキシ基のアシル化反応:
化合物(1)のうち、一般式
(式中、R,、R2、R3およびR5は前と同じ意味で
あり、R4fは非置換低級ァルカノィルオキシ、Nーア
ルキルーN−アラルキルアミノ低級アルカノイルオキシ
もしくはモノハロアリールオキシ低級アルカノィルオキ
シで置換されたアルキル基を意味する)で示される化合
物は、一般式
(式中、R,、R2、R3、R4eおよびR5は前と同
じ意味)で示される化合物にアシル化剤を作用させるこ
とにより製造することができる。5 Acylation reaction of hydroxyl group: Among compound (1), the general formula (wherein R,, R2, R3 and R5 have the same meanings as before, R4f is unsubstituted lower alkanoyloxy, N-alkyl group A compound represented by the general formula (meaning an alkyl group substituted with N-aralkylamino lower alkanoyloxy or monohaloaryloxy lower alkanoyloxy) is a compound represented by the general formula (wherein R,, R2, R3, R4e and R5 are It can be produced by reacting a compound represented by (same meaning as above) with an acylating agent.
このアシル化反応で用いられる原料化合物(1‐5)は
前記の方法4で製造される。The raw material compound (1-5) used in this acylation reaction is produced by the method 4 described above.
この反応で用いられるアシル化剤とは一般式R9一〇H
(m)(式中、R9は非置換
低級アルカノィル、NーアルキルーNーアラルキルアミ
ノ低級アルカノイルもしくはモノハロアリールオキシ低
級アルカノィルを意味する)で示される化合物およびそ
の反応性誘導体を意味する。The acylating agent used in this reaction has the general formula R910H
(m) (wherein R9 means unsubstituted lower alkanoyl, N-alkyl-N-aralkylamino lower alkanoyl or monohaloaryloxy lower alkanoyl) and reactive derivatives thereof.
アシル化剤(m)の好ましい例としては、譲酸、酢酸、
プロピオン酸、酪酸、ィソ酪酸、青草酸、ィソ吉草酸、
ピバル酸等の低級アルカン酸、2(または3)−(N−
メチル−N−ペンジルアミノ)プロピオン酸等のN−ア
ルキルーN−アラルキルアミノ低級アルカン酸、2(ま
たは3または4)ークロロフェノキシ酢酸、2−〔2(
または3または4)−クロロフエノキシ〕プロピオン酸
等のモノハロアリールオキシで置換された低級アルカン
酸が挙げられる。上記のようなカルポン酸(m)の反応
性誘導体としては酸ハラィド、酸無水物、活性アミド、
アジドメチルエステル、エチルエステル、シアノメチル
エステル、p−ニトロフエニルエステル等の活性ェステ
ル等が挙げられる。この反応は通常ピリジン、エーテル
、ジオキサン、アセトン、1クロロホルム、塩化メチレ
ン、テトラヒドロフラン、ジメチルホルムアミド、ベン
ゼン、水またはその他のこの反応に悪影響を与えない溶
媒中で行なわれ、塩基の存在下で好ましく進行する。Preferred examples of the acylating agent (m) include yield acid, acetic acid,
Propionic acid, butyric acid, isobutyric acid, cyanobic acid, isovaleric acid,
lower alkanoic acids such as pivalic acid, 2(or 3)-(N-
N-alkyl-N-aralkylamino lower alkanoic acids such as methyl-N-pendylamino)propionic acid, 2(or 3 or 4)-chlorophenoxyacetic acid, 2-[2(
or 3 or 4)-chlorophenoxy] lower alkanoic acids substituted with monohaloaryloxy such as propionic acid. The above-mentioned reactive derivatives of carboxylic acid (m) include acid halides, acid anhydrides, activated amides,
Examples include active esters such as azidomethyl ester, ethyl ester, cyanomethyl ester, and p-nitrophenyl ester. This reaction is usually carried out in pyridine, ether, dioxane, acetone, 1 chloroform, methylene chloride, tetrahydrofuran, dimethylformamide, benzene, water or other solvents that do not adversely affect the reaction, and preferably proceeds in the presence of a base. .
この塩基の例としては、水酸化ナトリウム、水酸化カリ
ウム、軍炭酸ナトIJウム、重炭酸カリウム、炭酸ナト
リウム、炭酸カリウム等の無機塩基、N−メチルピベリ
ジン、トリエチルアミン、ピリジン、N−メチルモルホ
リン、N・N−ジメチルアニリン等の有機塩基が挙げら
れる。反応温度は特に限定されず、通常冷却下、室温、
加温下で行なわれる。また、必要に応じて、縮合剤とし
て−対史に繁用されているオキシ塩化りん、チオニルク
ロライド、N・N′ージシクロヘキシルカルボジイミド
、N−シクロヘキシル−N′ーモルホリノエチルカルポ
ジイミド、ベンタメチレンケテン一N−シクロヘキシル
イミン、アルコキシアセチレン、2−エチル−7ーヒド
ロキシイソキサゾリウム塩、水酸化2ーェチル−5−(
mースルホフエニル)インキサゾリウム、6−クロロー
1−トシルオキシベンゾトリアゾール等を用いることが
できる。上記の方法において、生成した目的化合物はい
ずれも常法により単離採取される。Examples of such bases include inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, N-methylpiveridine, triethylamine, pyridine, N-methylmorpholine, N. Examples include organic bases such as N-dimethylaniline. The reaction temperature is not particularly limited, usually under cooling, room temperature,
It is carried out under heating. In addition, as a condensing agent, if necessary, phosphorus oxychloride, thionyl chloride, N-N'-dicyclohexylcarbodiimide, N-cyclohexyl-N'-morpholinoethylcarpodiimide, bentamethylene ketene, etc. N-cyclohexylimine, alkoxyacetylene, 2-ethyl-7-hydroxyisoxazolium salt, 2-ethyl-5-(hydroxide)
m-sulfophenyl)inxazolium, 6-chloro-1-tosyloxybenzotriazole, etc. can be used. In the above method, any target compound produced is isolated and collected by conventional methods.
この発明で使用される化合物(1)には、その1・4−
ジヒドロピリジン環4位の不斎炭素に由来する立体異性
体が存在し、化合物(1)のあるものはその1・4−ジ
ヒドロピリジン環の2、3、5および6位の置換基中に
さらに1個以上の不斎炭素を有するものもある。Compound (1) used in this invention includes 1,4-
There are stereoisomers derived from the non-sacrificial carbon at the 4-position of the dihydropyridine ring, and some of compound (1) have one additional substituent at the 2-, 3-, 5-, and 6-positions of the 1,4-dihydropyridine ring. Some have more inhospitable carbon.
これらの場合には、化合物(1)はそれぞれの光学異性
体またはラセミ体、さらにジアステレオーマーまたはそ
れらの混合体として存在することができる。ジアステレ
オーマ−の混合体は必要に応じてクロマトグラフィーま
たは分別再結晶等の常法によりそれぞれのラセミ体に分
割することができ、さらに例えば分子内に塩基性官能基
または酸性官能基を有する化合物については、それぞれ
、光学活性を有する酒石酸、カンフアースルホン酸等の
駿またはェフェドリン、ストリキニーネ等の塩基との塩
に導き、それを分別再結晶により分割するなどの常法に
従って、それぞれの光学異性体に分割することができる
。この発明で使用される化合物(1)は血管拡張作用お
よび血圧下降作用を有し、高血圧症や心不全、狭心症、
心筋梗塞等の循環器系疾病に対して有効である。In these cases, compound (1) can exist as each optical isomer or racemate, as well as a diastereomer or a mixture thereof. Mixtures of diastereomers can be separated into their respective racemates by conventional methods such as chromatography or fractional recrystallization, if necessary. , respectively, into optically active salts such as tartaric acid and camphorsulfonic acid or bases such as ephedrine and strychnine, which are then separated into their respective optical isomers by fractional recrystallization. can do. Compound (1) used in this invention has vasodilatory and blood pressure lowering effects, and can treat hypertension, heart failure, angina pectoris,
It is effective against cardiovascular diseases such as myocardial infarction.
この発明で使用される化合物(1)のうち、次式で示さ
れる化合物〔B〕〜〔N〕について公知の化合物〔A〕
と比較した薬理試験の結果を示す。Among the compounds (1) used in this invention, compounds [B] to [N] represented by the following formulas are known compounds [A]
The results of pharmacological tests compared with
【11試験化合物
〔注〕 公知化合物〔A〕は一般名ニフェジピン(Ni
fedipi股)として知られており、冠血管拡張剤と
して市販されている。[11 Test compounds [Note] Known compound [A] has the generic name nifedipine (Ni
It is commercially available as a coronary vasodilator.
‘21 試験結果 犬を用いた冠血管血流増加量は次に示す通りである。'21 Test results The amount of increase in coronary blood flow using dogs is as shown below.
結果は薬物無投与時〔29.5±5.5の【/分〕を対
照として、対照を100とした増加量を%で示した。(
i)各種投与量における化合[A〕〜〔E〕の試験結果
仙 投与量64〃夕/均における化合物〔虹おょび〔F
〕〜〔N〕の試験結果■ 試験方法
ペントバルビタールで麻酔した犬に彼験化合物を静脈内
投与し、常法に従って冠血管血流量を測定し、各投与量
における冠血管血流量の最大値(似/分)を求めた。The results are expressed as a percentage of the increase when no drug was administered [29.5±5.5/min], with the control being 100. (
i) Test results of compounds [A] to [E] at various doses.
] ~ [N] test results■ Test method The test compound was administered intravenously to a dog anesthetized with pentobarbital, and the coronary blood flow was measured according to the standard method, and the maximum value of the coronary blood flow at each dose ( (same/minute) was calculated.
この発明の化合物(1)はその有効かつ非毒性量を含有
する組成物の形で投与される。Compound (1) of this invention is administered in the form of a composition containing an effective and non-toxic amount thereof.
この組成物は医薬の製剤において慣用されている無機も
しくは有機あるいは固体または液体の製剤用担体ととも
に経口または非経口投与に適した剤形で使用される。好
ましい剤形としては、錠剤、顎粒剤、粉剤、散剤、カプ
セル剤、舌下錠剤、坐剤、水剤、シロップ剤、注射剤等
が挙げられる。固体または液体の製剤用担体の例として
は、ラクトース、ステアリン酸マグネシウム、庶糖、コ
ーンスターチ、タルク「ステアリン酸、ゼラチン、寒天
、ペクチン、アラビアゴム、ピーナツ油、オリーブ油、
ゴマ油、カカオ脂等が挙げられる。前記各種の製剤はそ
れぞれ周知の方法で製造することができる。この発明で
化合物(1)を医薬として用いる場合の投与量としては
、経口投与で1日量として0.1一500雌、好ましく
は1一50の夕が、また静脈内投与批1日量として経口
投与の市。This composition is used in a dosage form suitable for oral or parenteral administration together with inorganic or organic, solid or liquid pharmaceutical carriers commonly used in pharmaceutical formulations. Preferred dosage forms include tablets, jaw granules, powders, powders, capsules, sublingual tablets, suppositories, solutions, syrups, injections, and the like. Examples of solid or liquid pharmaceutical carriers include lactose, magnesium stearate, sucrose, corn starch, talc, stearic acid, gelatin, agar, pectin, gum arabic, peanut oil, olive oil,
Examples include sesame oil and cacao butter. Each of the above-mentioned various formulations can be manufactured by a well-known method. When compound (1) is used as a medicine in this invention, the dosage is 0.1 to 500 mg per day for oral administration, preferably 1 to 50 mg per day for intravenous administration. City of oral administration.
〜影適当な回数に分けて投与されるが、投与量は投与形
態、患者の性別、年令、体重、症状等を考慮して適宜選
択するのが好ましい。ここで、この発明で使用される化
合物(1)の急性毒性試験結果を示す。Although the drug is administered in appropriate doses, it is preferable to select the dose appropriately, taking into consideration the mode of administration, patient's sex, age, weight, symptoms, etc. Here, the acute toxicity test results of compound (1) used in this invention are shown.
【1’試験動物
JCL:SD系ラツト(6週令)
‘21 投与方法
1群各10匹とし、被鹸化合物を0.5%メチルセルロ
ース溶液に懸濁した後経口投与した。[1' Test animals JCL: SD rats (6 weeks old) '21 Administration method Each group consisted of 10 animals, and the compound to be saponified was suspended in a 0.5% methylcellulose solution and then administered orally.
■ 被験化合物4)試験結果
次に、この発明で使用される1・4ージヒドロピリジン
誘導体の製造法を実施例として示す。■Test Compound 4) Test Results Next, a method for producing the 1,4-dihydropyridine derivative used in the present invention will be shown as an example.
実施例 1‘1} 2ークロロベンズアルデヒド(14
.0570夕)、4・4−ジェトキシアセト酢酸エチル
ェステル(21.8240多)およびピベリジン(1の
‘)をベンゼン(100の‘)に溶解した溶液を4時間
共沸脱水条件下で加熱還流する。Example 1'1} 2-chlorobenzaldehyde (14
.. A solution of 4,4-jethoxyacetoacetic acid ethyl ester (21.8240%) and piveridine (1%) dissolved in benzene (100%) was heated to reflux under azeotropic dehydration conditions for 4 hours.
反応液を水洗乾燥後濃縮すると油状の2−(2−クロロ
ベンジリデン)一4・4ージェトキシアセト酢酸エチル
ェステルを得る。これと3ーアミノクロトン酸エチルェ
ステル(12.92夕)の混合物を油裕中約10び0で
加熱する。反応液を酢酸エチルに溶解し、水洗、乾燥後
溶媒を蟹去すると粗製油状物(52.4夕)を得る。こ
れを溶出溶媒(ベンゼン:酢酸エチル=20:1)を用
いて、シリカゲルカラムクロマトグラフイーに付して精
製し、得られた結晶をn−へキサンから再結晶すると、
mp75一770の2山メチル−4−(2ークロロフエ
ニル)一6ージエトキシメチルー1・4ージヒドロピリ
ジン−3・5−ジカルボン酸ジェチルヱステルの結晶(
20.2445夕)を得る。【2’ 2ークooベンズ
アルデヒド(2.81夕)、4・4−ジメトキシ−3−
オキソ青草酸〆チルエステル(3.81夕)、ピベリジ
ン(0.2の【)、ベンゼン(20泌)の混合物を7.
即時間共縦脱水条件下で加熱還流する。The reaction solution was washed with water, dried, and concentrated to obtain oily 2-(2-chlorobenzylidene)-4,4-jethoxyacetoacetic acid ethyl ester. A mixture of this and 3-aminocrotonic acid ethyl ester (12.92 ml) is heated in an oil bath at about 10 to 0 ml. The reaction mixture was dissolved in ethyl acetate, washed with water, dried, and the solvent was removed to obtain a crude oil (52.4 mm). This was purified by silica gel column chromatography using an elution solvent (benzene: ethyl acetate = 20:1), and the obtained crystals were recrystallized from n-hexane.
Crystals of diethyl ester of methyl-4-(2-chlorophenyl)-6-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylate of mp75-770 (
20.2445 evening) is obtained. [2' 2-koo benzaldehyde (2.81 m), 4,4-dimethoxy-3-
7. Add a mixture of oxococyanate methyl ester (3.81 hours), piberidine (0.2 hours), and benzene (20 hours).
Immediately heat to reflux under vertical dehydration conditions.
反応液に少量のベンゼンを加え、水洗後硫酸マグネシウ
ムで乾燥する。得られた2−(2ークロロベンジリデン
)一4・4ージメトキシー3ーオキソ青草酸〆チルェス
テルの赤色油状物質(7.04夕)と3ーアミノクロト
ン酸メチルェステル(2.33夕)の混合物を1320
で3.期時間加熱し、反応液を放冷後酢酸エチルに溶解
する。得られた溶液を水、次いで塩化ナトリウム水溶液
で洗浄後、硫酸マグネシウムで乾燥し、減圧下溶媒を留
去すると粘着性の褐色油状物質(8.28夕)を得る。
この油状物質を溶出溶媒(ベンゼン:酢酸エチル=20
:1)を用いてシリカゲルカラムクロマトグラフィーに
付すと油状物質(5.26夕)を得る。この油状物質を
酢酸エチルとジェチルェーテルの混液に溶解し、溶媒を
減圧下で留去すると無色粉末(1.0625夕)を得る
。この粉末をn−へキサンおよび酢酸エチルの濠液から
再結晶するとmp145一14600の淡黄色粒状晶の
2ーメチル−4一(2ークロロフエニル)一6一(1・
1ージメトキシエチル)−1・4ージヒドロピリジンー
3・5ージカルボン酸ジメチルェステルを得る。‘3’
2−ニトロベンズアルデヒド(9.0672夕)、4
・4ージェトキシアセト酢酸エチルェステル(13.0
944夕)およびピベリジン(1の上)をベンゼン(4
5泌)に溶解した溶液を3時間共荻脱水条件下で加熱還
流する。Add a small amount of benzene to the reaction solution, wash with water, and then dry with magnesium sulfate. A mixture of the obtained red oily substance of methyl ester of 2-(2-chlorobenzylidene)-4,4-dimethoxy-3-oxocyanate (7.04 evening) and 3-aminocrotonic acid methyl ester (2.33 evening) was heated to 1320 ml.
So 3. After heating for a period of time, the reaction solution was allowed to cool and then dissolved in ethyl acetate. The resulting solution was washed with water and then with an aqueous sodium chloride solution, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain a sticky brown oil (8.28 pm).
This oily substance was mixed with an elution solvent (benzene: ethyl acetate = 20
When subjected to silica gel column chromatography using 1), an oily substance (5.26 min.) is obtained. This oil was dissolved in a mixture of ethyl acetate and diethyl ether, and the solvent was distilled off under reduced pressure to give a colorless powder (1.0625 mm). When this powder was recrystallized from a solution of n-hexane and ethyl acetate, pale yellow granular crystals of mp145-14600 were obtained.
1-dimethoxyethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester is obtained. '3'
2-nitrobenzaldehyde (9.0672 evening), 4
・4-Jethoxyacetoacetic acid ethyl ester (13.0
944) and piveridine (1) to benzene (4)
A solution dissolved in 5-glycerol is heated under reflux under conditions of dehydration for 3 hours.
反応液に水を加え、酢酸エチルで抽出する。抽出液を3
回水洗し、乾燥後減圧下で溶媒を留去する。得られた2
−(2ーニトoベンジリデン)一4・4−ジエトキシア
セト酢酸エチルヱステルの粗製油状物質と3ーアミノク
ロトン酸エチルェステル(7.7496のの混合物を油
浴中90一100℃で8時間加熱する。Add water to the reaction solution and extract with ethyl acetate. 3 extracts
After washing with water twice and drying, the solvent is distilled off under reduced pressure. Obtained 2
A mixture of the crude oil of ethyl -(2nitobenzylidene)-4,4-diethoxyacetoacetate and ethyl 3-aminocrotonic acid ester (7.7496) is heated in an oil bath at 90-100°C for 8 hours.
反応混合物をジェチルェーテルで抽出し、抽出液を水洗
乾燥後溶媒を留去する。残留物を顔出溶媒(ベンゼン:
酢酸エチル=20:1)を用いてシリカゲルカラムクロ
マトグラフィーに付して精製すると油状の2ーメチルー
4一(2ーニトロフエニル)一6ージエトキシメチル−
1・4ージヒドロピリジン−3・5ージカルボン酸ジェ
チルェステル(19.3夕)を得る。この油状物質をn
ーヘキサンで結晶化し、n−へキサンと酢酸エチルの混
液から再結晶するとmp80−81.500の黄色粒状
晶を得る。■ 実施例1−【1)と同様にして、3−ニ
トロベンズアルデヒド(2.27夕)、4・4ージエト
キシアセト酢酸エチルェステル(3.28夕)、ピベリ
ジン(0.2叫)およびベンゼン(15の‘)を用いて
製造された油状の2一(3ーニト。ペンジリデン)−4
.4ージェトキシアセト酢酸エチルェステル(6.0夕
)と3ーアミノクロトン酸エチルェステル(1.94夕
)から油状物質(7.8夕)を得る。この樹状物質を溶
出溶媒(ベンゼン:酢酸エチル=20:1)を用いてシ
リカゲルクロマトグラフィーに付して精製すると、2−
メチル一4一(3ーニトロフエニル)一6ージヱトキシ
メチル−1・4−ジヒドロピリジンー3・5−ジカルボ
ン酸ジェチルェステル(4.65夕)を得る。赤外線吸
収スペクトル(フィルム)
3400、1690、1615、1530、1480、
1350、1280、120リ1090、920、76
5弧‐1核磁気共鳴吸収スペクトル(6、CDC13)
1.231.26(12日、t、t、J=7Hz)、2
.4(洲、s)、3.5‐3.86(4日、m)、4.
11(』日、q、J=7日2)、5.16(IH、s)
、6.82(IH、broad)、7‐25一8‐16
(虹日、m)■ 2一(2ートリフルオロメチルベンジ
リデン)−4・4−ジヱトキシアセト酢酸エチルェステ
ル(7.48夕)および3ーアミノクロトン酸エチルェ
ステル(2.582夕)の混合物を130qoで5時間
加熱する。The reaction mixture was extracted with diethyl ether, the extract was washed with water, dried, and the solvent was distilled off. Remove the residue from the solvent (benzene:
Purification by silica gel column chromatography using ethyl acetate (20:1) yields an oily 2-methyl-4-(2-nitrophenyl)-6-diethoxymethyl-
1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (19.3 evening) is obtained. This oily substance is
- Crystallization from hexane and recrystallization from a mixture of n-hexane and ethyl acetate gives yellow granular crystals with a mp of 80-81.500. ■ In the same manner as in Example 1-[1], 3-nitrobenzaldehyde (2.27 hours), 4,4-diethoxyacetoacetic acid ethyl ester (3.28 hours), piveridine (0.2 hours) and benzene ( Oily 2-(3 nit.penzylidene)-4 prepared using 15')
.. An oil (7.8 min.) is obtained from 4-jethoxyacetoacetic acid ethyl ester (6.0 min.) and 3-aminocrotonic acid ethyl ester (1.94 min.). When this dendritic material was purified by silica gel chromatography using an elution solvent (benzene: ethyl acetate = 20:1), 2-
Methyl-41(3-nitrophenyl)-16-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (4.65 yen) is obtained. Infrared absorption spectrum (film) 3400, 1690, 1615, 1530, 1480,
1350, 1280, 120ri 1090, 920, 76
5-arc-1 nuclear magnetic resonance absorption spectrum (6, CDC13)
1.231.26 (12th, t, t, J=7Hz), 2
.. 4 (Su, s), 3.5-3.86 (4th, m), 4.
11 ('day, q, J = 7 days 2), 5.16 (IH, s)
, 6.82 (IH, broad), 7-25-8-16
(Rainbow Day, m) ■ A mixture of 2-(2-trifluoromethylbenzylidene)-4,4-diethoxyacetoacetic acid ethyl ester (7.48 pm) and 3-aminocrotonic acid ethyl ester (2.582 pm) was heated at 130 qo for 5 hours. do.
反応液を酢酸エチルに溶解した溶液を2回水洗し、乾燥
後減圧下で濃縮する。得られた赤色油状残澄(9.8の
を溶出溶媒(ベンゼン:ジヱチルェーテルこ20:1)
を用いてシリカゲルカラムクロマトグラフイーに付す。
得られた油状物質は結晶化し、これをnーヘキサンとジ
ェチルェーテルの濠液から再結晶するとmp82−83
qoの2ーメチルー4−(2ートリフルオロメチルフエ
ニル)−6ージエトキシメチルー1・4−ジヒドロピリ
ジン−3・5−ジカルボン酸ジェチルェステルの結晶を
得る。{6)2−クロロー5ーニトロベンズアルデヒド
(3.73夕)、414ージェトキシアセト酢酸エチル
エステル(4.365夕)、ピベリジン(272.5の
9)およびベンゼン(10の【)からなる混合物を1.
曲時間共沸脱水条件下で加熱還流する。A solution of the reaction mixture in ethyl acetate is washed twice with water, dried, and concentrated under reduced pressure. The resulting red oily residue (9.8) was eluted with a solvent (benzene:diethyl ether, 20:1).
Subject to silica gel column chromatography using
The obtained oil was crystallized and recrystallized from a solution of n-hexane and diethyl ether to give mp82-83.
Crystals of 2-methyl-4-(2-trifluoromethylphenyl)-6-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester of qo are obtained. {6) A mixture consisting of 2-chloro-5-nitrobenzaldehyde (3.73 mm), 414-jethoxyacetoacetic acid ethyl ester (4.365 mm), piveridine (9 of 272.5) and benzene (10) 1.
Heat to reflux under azeotropic dehydration conditions.
反応液に酢酸エチルを加え、3回水洗後塩化ナトリウム
水溶液で洗浄し乾燥する。溶媒を減圧下で蟹去し、得ら
れた2−(2ークロロ−5ーニトロベンジリデン)一4
・4ージエトキシアセト酢酸エチルェステルの赤褐色油
状物質(7.87夕)に3−アミノクロトン酸エチルェ
ステル(3.48夕)を加えて油裕上105−107q
0で4.虫時間加熱損拝する。反応液を酢酸エチルで抽
出し、抽出液を塩化ナトリウム水溶液で3回洗浄後硫酸
マグネシウムで乾燥する。溶媒を蟹去し、磯澄(10.
872)を溶出溶媒(クロロホルム:酢酸エチルi20
:1)を用いてシリカゲルクロマトグラフィーに付し、
得られたフラクションを薄層クロマトグラフィーで追跡
して、目的とする生成物を含むフラクションから結晶(
6.02夕)を得る。この結晶をジェチルェーテルとn
−へキサンの混液から再結晶するとmpl17−11が
○の2−メチル一4−(2ークロロー5−ニトロフエニ
ル)一6−ジヱトキシメチル−1・4ージヒドロピリジ
ンー3・5ージカルボン酸ジェチルェステルの結晶を得
る。{7} 2ーニトロベンズアルデヒド(3.02夕
)、アセト酢酸の2−ェトキシェチルェステル(3.4
8夕)、ピベリジン(272.5雌)およびベンゼン(
10の‘)の混合物を英沸脱水条件下で1.虫時間加熱
還流する。Add ethyl acetate to the reaction solution, wash with water three times, then wash with aqueous sodium chloride solution and dry. The solvent was removed under reduced pressure, and the obtained 2-(2-chloro-5nitrobenzylidene)-4
・Add 3-aminocrotonic acid ethyl ester (3.48 evenings) to the reddish brown oily substance of 4-diethoxyacetoacetic acid ethyl ester (7.87 evenings) and make it on Yuyu 105-107q.
0 and 4. Insect time heat loss. The reaction solution was extracted with ethyl acetate, the extract was washed three times with an aqueous sodium chloride solution, and then dried over magnesium sulfate. The solvent was removed and Isosumi (10.
872) as an elution solvent (chloroform:ethyl acetate i20
: Subjected to silica gel chromatography using 1),
The obtained fractions were followed by thin layer chromatography, and crystals (
6.02 evening). This crystal is called jetyl ether.
Recrystallization from a mixed solution of -hexane gives crystals of 2-methyl-4-(2-chloro-5-nitrophenyl)-16-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester with mpl17-11 of ○. {7} 2-nitrobenzaldehyde (3.02), 2-ethoxychetyl ester of acetoacetic acid (3.4)
8 nights), piberidine (272.5 females) and benzene (
The mixture of 10') was heated under boiling dehydration conditions. Heat to reflux for an hour.
反応液を3回水洗し、次いで塩化ナトリウム水溶液で洗
浄後硫酸マグネシウムで乾燥し、濃縮する。得られた油
状の2−(2−ニトロベンジリデン)アセト酢酸の2−
ェトキシエチルヱステルに3ーアミノー4・4ージエト
キシクロトン酸エチルエステル(4.77夕)を加え、
110つ○で5時間加熱燈梓する。反応液を酢酸エチル
で抽出し、抽出液を3回水洗後硫酸マグネシウムで乾燥
する。溶媒を蟹去し、褐色油状残漣を溶出溶媒(ベンゼ
ン:酢酸エチル=10:1)を用いてシリカゲルカラム
クロマトグラフィーに付して精製すると油状の2ーメチ
ルー4−(2ーニトロフエニル)一5ーエトキシカルボ
ニル一6ージエトキシメチルー1・4−ジヒドロピリジ
ンー3−カルボン酸の2−ェトキシェチルェステル(3
.18夕)を得る。赤外線吸収スペクトル(フィルム)
3420、1730、1695、1650、1610、
1530、1480、1355、1275121○11
00、860、830、78ふ 752・715肌‐1
核磁気共鳴吸収スペクトル(6、CDC13)1‐1.
37(12日、m)、2.37(が、s)、3.28‐
4,3(1が、m)、5・93(IH、s)、6.2(
IH、s)、6.78(IH、m)、7.23−7.8
3(岬、m){8} 実施例1−‘7’と同様にして、
2ーニトロベンズアルデヒド(3.02夕)、アセト酢
酸の2ーベンジルオキシエチルエステル(4.72夕)
、ピベリジン(272.5の9)およびベンゼン(10
.8の【)から製造した2−(2ーニトロベンジリデン
)アセト酢酸の2ーベンジルオキシェチルェステルに3
ーアミノー4・4ージヱトキシクロトン酸エチルェステ
ルを作用させて油状の2−メチル一4−(2−ニトロフ
エニル)一5−エトキシカルポニル−6ージエトキシメ
チル−1・4ージヒドロピリジンー3ーカルボン酸の2
ーベンジルオキシェチルェステル(4.80夕)を得る
。The reaction solution was washed three times with water, then with an aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated. The resulting oily 2-(2-nitrobenzylidene)acetoacetic acid
Add 3-amino-4,4-diethoxycrotonic acid ethyl ester (4.77 pm) to ethoxyethyl ester,
Heat at 110 ○ for 5 hours. The reaction solution was extracted with ethyl acetate, the extract was washed three times with water, and then dried over magnesium sulfate. The solvent was removed and the brown oily residue was purified by silica gel column chromatography using an eluent (benzene:ethyl acetate = 10:1) to obtain oily 2-methyl-4-(2nitrophenyl)-5-ethoxy. 2-ethoxychetyl ester of carbonyl-6-diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid (3
.. 18 evening). Infrared absorption spectrum (film)
3420, 1730, 1695, 1650, 1610,
1530, 1480, 1355, 1275121○11
00, 860, 830, 78fu 752/715 skin-1
Nuclear magnetic resonance absorption spectrum (6, CDC13) 1-1.
37 (12th, m), 2.37 (ga, s), 3.28-
4,3 (1 is, m), 5・93 (IH, s), 6.2 (
IH, s), 6.78 (IH, m), 7.23-7.8
3 (Misaki, m) {8} Example 1 - Same as '7',
2-nitrobenzaldehyde (3.02 evenings), 2-benzyloxyethyl ester of acetoacetic acid (4.72 evenings)
, piveridine (9 of 272.5) and benzene (10
.. 3 to 2-benzyloxyethyl ester of 2-(2-nitrobenzylidene)acetoacetic acid prepared from [) of 8.
-Amino-4,4-diethoxycrotonic acid ethyl ester was reacted with oily 2-methyl-4-(2-nitrophenyl)-5-ethoxycarponyl-6-diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid. 2
-benzyloxyethyl ester (4.80 pm) was obtained.
赤外線吸収スペクトル
3400、1700、1650、1610、1530、
1480、13551273120ふ10901055
750、700肌核磁気共鳴吸収スペクトル(6、C
DC13)1.1‐1.3(畑、m)、2.32(細、
s)、3.45‐4.32(1皿、m)、4.46(が
、s)、5・94(IH、s)、6.2(IH、s)、
6.82(IH、s)、7.16−7.74(班、m)
‘91 実施例1一のと同機にして、3ーニトロベンズ
アルデヒド(4.54夕)、アセト酢酸の2−ェトキシ
エチルエステル(5.23夕)、ピベリジン(85.2
雌)およびベンゼン(15の【)から製造した油状の2
−(3ーニトロベンジリデン)アセト酢酸の2ーェトキ
シェチルェステルに3ーアミノ−4・4−ジェトキシク
ロトン酸エチルェステル(6.5夕)を作用させて得ら
れた結晶をn−へキサンとジェチルェーテルの濠液から
再結晶するとmp99−100℃の黄色粒状晶の2ーメ
チル−4−(3−ニトロフエニル)一5−エトキシカル
ボニル−6ージエトキシメチルー1・4ージヒドロピリ
ジン−3−カルボン酸の2ーェトキシヱチルェステル(
565.2倣)を得る。Infrared absorption spectrum 3400, 1700, 1650, 1610, 1530,
1480, 13551273120fu10901055
750, 700 skin nuclear magnetic resonance absorption spectrum (6, C
DC13) 1.1-1.3 (field, m), 2.32 (thin,
s), 3.45-4.32 (1 plate, m), 4.46 (ga, s), 5.94 (IH, s), 6.2 (IH, s),
6.82 (IH, s), 7.16-7.74 (group, m)
'91 Example 1 In the same aircraft, 3-nitrobenzaldehyde (4.54 hours), 2-ethoxyethyl ester of acetoacetic acid (5.23 hours), and piverizine (85.2 hours) were prepared.
2) and benzene (15 [)]
The crystals obtained by reacting 2-ethoxychetyl ester of -(3nitrobenzylidene)acetoacetic acid with 3-amino-4,4-jethoxycrotonate ethyl ester (6.5 yen) were combined with n-hexane. Recrystallization from diethyl ether solution yields 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid as yellow granular crystals with a mp of 99-100°C. 2-ethoxyethyl ester (
565.2 imitation).
00 2ークロロベンズアルデヒド(351.4の9)
、4・4−ジェトキシアセト酢酸エチルェステル(54
5.6の3)、3ーアミノクロトン酸エチルェステル(
322.9の9)およびnープロパノール(2の【)の
混合物を1m時間還流する。00 2-chlorobenzaldehyde (351.4-9)
, 4,4-jethoxyacetoacetic acid ethyl ester (54
5.6-3), 3-aminocrotonic acid ethyl ester (
A mixture of 322.9 of 9) and n-propanol (2 of [)] is refluxed for 1 m hour.
反応液を濃縮し、得られた残繕をエーテルに溶解し、2
回水洗する。抽出液を乾燥後溶媒を留去して得られた澄
色油状物質(1.1765のを溶出溶媒(ベンゼン:酢
酸エチル=20:1)を用いてシリカゲルカラムクロマ
トグラフイーに付して精製すると油状物質(374.6
の9)を得る。これをn−へキサンに溶解し、冷所に放
置する。析出する結晶を炉敬し、nーヘキサンで洗浄す
るとmp75−770の2−メチル−4一(2−クロロ
フエニル)一6−ジエトキシメチルー1・4ージヒドロ
ピリジン−3・5ージカルポン酸ジェチルェステルの結
晶(374.6の9)を得る。OU 同様にして、次の
化合物を得る。The reaction solution was concentrated, the resulting residue was dissolved in ether, and 2
Wash twice with water. After drying the extract, the solvent was distilled off, and the resulting clear color oil (1.1765) was purified by silica gel column chromatography using an eluent (benzene: ethyl acetate = 20:1). Oily substances (374.6
9) is obtained. Dissolve this in n-hexane and leave in a cool place. The precipitated crystals were filtered and washed with n-hexane to give crystals of 2-methyl-4-(2-chlorophenyl)-16-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester of mp75-770 ( 9) of 374.6 is obtained. OU The following compound is obtained in the same manner.
{1)2ーメチル−4一(3−ニトロフエニル)−5ー
エトキシカルボニル一6ージエトキシメチルー1・4ー
ジヒドロピリジンー3一力ルポン酸の2−(N−ペンジ
ル−Nーメチルアミノ)エチルエステル赤外線吸収スペ
クトル(フィルム)
3400、1700、1690、1610、1528、
1475、135012761197、1092、10
5ふ 755 698狐一1核磁気共鳴吸収スペクトル
(6、CDC13十D20)1.21(班、t、J=7
HZ)、2.21(が、s)、2.36(班、s)、2
.63(が、t、J;6HZ)、3.5(が、s)、3
.65(が、q、J=7HZ)、3.66(が、q、J
=7HZ)、4,1(が、q)、4,18(が、t、J
=6HZ)、5.18(IH、s)、6.2(IH、s
)、6.86(IH、s)、7.16−8.16(4日
、m)■ 2ーメチル−4−(2−ニトロフエニル)−
6ーエチレンジオキシメチル−1・4−ジヒドロピリジ
ンー3・5ージカルボン酸ジヱチルエステル(mpl5
2一153.5℃)実施例 2{1)2ーメチルー4一
(2ークロロフエニル)一6ージエトキシメチル−1・
4ージヒドロピリジンー3・5−ジカルポン酸ジェチル
ェステル(452の夕)のァセトン(5の‘)の溶液に
洲−塩酸(0.2〜0.3の‘)を加え、室温で1時間
蝿拝する。{1) Infrared 2-(N-penzyl-N-methylamino)ethyl ester of 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-diethoxymethyl-1,4-dihydropyridine-3 monoluponic acid Absorption spectrum (film) 3400, 1700, 1690, 1610, 1528,
1475, 135012761197, 1092, 10
5fu 755 698 Fox 11 nuclear magnetic resonance absorption spectrum (6, CDC130D20) 1.21 (group, t, J=7
HZ), 2.21 (ga, s), 2.36 (ban, s), 2
.. 63 (ga, t, J; 6HZ), 3.5 (ga, s), 3
.. 65 (ga, q, J = 7HZ), 3.66 (ga, q, J
=7HZ), 4,1 (ga, q), 4,18 (ga, t, J
=6HZ), 5.18 (IH, s), 6.2 (IH, s
), 6.86 (IH, s), 7.16-8.16 (4 days, m) ■ 2-Methyl-4-(2-nitrophenyl)-
6-ethylenedioxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (mpl5
2-153.5℃) Example 2{1) 2-methyl-4-(2-chlorophenyl)-6-diethoxymethyl-1.
Add hydrochloric acid (0.2-0.3') to a solution of 4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (452 evening) in acetone (5') and stir at room temperature for 1 hour. .
溶媒を蟹去し、残澄を酢酸エチルで2回抽出後抽出液を
水洗乾燥する。溶媒を蟹去すると油状残澄が得られ、こ
れは結晶化する。この結晶をnーヘキサンとジェチルェ
ーテルの涙液から再結晶すると、mp87−88℃の黄
燈色粒状晶の2ーメチルー4一(2ークロロフエニル)
−6−ホルミルー1・4ージヒドロビリジンー3・5−
ジカルボン酸ジェチルェステルを得る。‘21 2ーメ
チル−4−(2ークロロフエニル)一6−(1・1ージ
メトキシエチル)−1・4−ジヒドロピリジン−315
−ジカルボン酸ジメチルエステル(409.9の2)の
アセトン(15の【)の溶液に鮒‐塩酸(0.5の‘)
を加え、室温で17分間縄拝する。The solvent was removed, the residue was extracted twice with ethyl acetate, and the extract was washed with water and dried. Stripping off the solvent gives an oily residue which crystallizes. When this crystal is recrystallized from a tear fluid of n-hexane and diethyl ether, it produces 2-methyl-4-(2-chlorophenyl) as yellowish granular crystals with an mp of 87-88°C.
-6-formyl-1,4-dihydroviridine-3,5-
Dicarboxylic acid diethyl ester is obtained. '21 2-Methyl-4-(2-chlorophenyl)-6-(1,1-dimethoxyethyl)-1,4-dihydropyridine-315
- Carp in a solution of dicarboxylic acid dimethyl ester (409.9 2) in acetone (15 [)] - Hydrochloric acid (0.5 ')
Add to the mixture and stir at room temperature for 17 minutes.
反応液を重炭酸ナトリウム飽和水溶液で中和し、減圧下
溶媒を留去する。残燈に水を加え放置すると結晶が析出
する。この結晶(350.2の9)を炉取し、乾燥後n
−へキサンと酢酸エチルの混液から再結晶するとmp1
61一16?0の黄色粒状晶の2ーメチルー4一(2−
クロロフヱニル)一6−アセチル−1・4ージヒドロピ
リジンー3・5ージカルボン酸ジメチルェステルを得る
。【31 2ーメチル−4一(2ーニトロフエニル)一
6−ジエトキシメチルー1‘4ージヒドロピリジン−3
・5ージカルボン酸ジェチルェステル(1.1563夕
)のァセトン(10の‘)の溶液に鮒‐塩酸(2.5泌
)を加え室温で30分間蝿辞する。The reaction solution was neutralized with saturated aqueous sodium bicarbonate solution, and the solvent was evaporated under reduced pressure. If you add water to the afterlight and leave it for a while, crystals will precipitate. This crystal (9 of 350.2) was taken in a furnace, and after drying, n
-When recrystallized from a mixture of hexane and ethyl acetate, mp1
61-16?0 yellow granular crystals of 2-methyl-4-(2-
(chlorophenyl)-6-acetyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester. [31 2-Methyl-4-(2nitrophenyl)-6-diethoxymethyl-1'4-dihydropyridine-3
・To a solution of 5-dicarboxylic acid diethyl ester (1.1563 mm) in acetone (10 mm), add carp-hydrochloric acid (2.5 mm) and stir at room temperature for 30 minutes.
溶媒を蟹去し、銭澄に水を加え、次いで重炭酸ナトリウ
ム水溶液で中和する。析出する固形物を炉取し、水洗乾
燥すると黄色粉末(0.処07夕)を得る。これをnー
ヘキサンとエタノールの鷹液から再結晶するとmplo
l一103℃の2−メチル一4一(2ーニトロフエニル
)−6−ホルミルー1・4−ジヒドロビリジンー3・5
−ジカルボン酸ジェチルェステルの結晶を得る。【41
2ーメチルー4一(3ーニトロフヱニル)一6ージエ
トキシメチルー1・4−ジヒドロピリジンー3・5−ジ
カルボン酸ジェチルェステル(462.5の9)のァセ
トン(4の【)の溶液に鮒‐塩酸(0.4泌)を加え、
室温で1時間蝿拝する。溶媒を蟹去し、残溝に水を加え
て粉末化する。粉末を炉敬し水洗後乾燥するとmp13
0−133℃の2ーメチルー4−(3−ニトロフエニル
)一6ーホルミル−1・4ージヒドロピリジン−3・5
ージカルボン酸ジェチルェステル(360mo)を得る
。【512ーメチルー4−(2ートリフルオロメチルフ
エニル)一6ージエトキシメチルー1・4−ジヒドロピ
リジンー3・5ージカルポン酸ジェチルエステル(5.
2夕)のアセトン(5の‘)の溶液に鮒塩酸(5私)を
加え、室温で1.虫時間瀦拝する。The solvent is removed, water is added to the liquid, and then neutralized with aqueous sodium bicarbonate solution. The precipitated solids are collected in an oven, washed with water and dried to give a yellow powder (0.07 mm). When this is recrystallized from n-hexane and ethanol solution, mplo
2-Methyl-4-(2nitrophenyl)-6-formyl-1,4-dihydrobiridine-3,5 at 103°C
- Obtain crystals of dicarboxylic acid diethyl ester. [41
Add carp-hydrochloric acid (0) to a solution of 2-methyl-4-(3-nitrophenyl)-6-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (462.5-9) in acetone (4-[)]. Add .4 secretion),
Let stand for 1 hour at room temperature. The solvent is removed and water is added to the residue to form a powder. When the powder is heated in a furnace, washed with water and dried, it becomes MP13.
2-Methyl-4-(3-nitrophenyl)-6-formyl-1,4-dihydropyridine-3,5 at 0-133°C
-dicarboxylic acid diethyl ester (360 mo) is obtained. [512-Methyl-4-(2-trifluoromethylphenyl)-6-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (5.
Add carp hydrochloric acid (5 parts) to a solution of acetone (5 parts) of 1 part at room temperature. Worshiping insect time.
減圧下溶媒を蟹去し残澄を酢酸エチルで2回抽出する。
抽出液を水洗乾燥後溶媒を留去すると赤色油状の2−メ
チル一4一(2−トリフルオロメチルフエニル)一6ー
ホルミル−1・4ージヒドロピリジンー3・5−ジカル
ポン酸ジェチルェステル(4.2夕)を得る。赤外線吸
収スペクトル(ヌジョール)3350、1700、16
40、1605、1480、1370、130&120
以110QI03ふ950763弧‐1核磁気共鳴吸収
スペクトル(6、CDC13十D20)1,2(紺、t
、J=7HZ)、2.4(3日、s)、3‐92−4‐
38(山日、m)、5‐72(IH、S)、7.06(
IH、s)、7.24−7.62(4日、m)【6)
2−メチル一4一(2−クロロー5ーニトロフエニル)
一6ージエトキシメチルー1・4ージヒドロピリジン−
3・5−ジカルボン酸ジェチルエステル(5.45のの
アセトン(54.5の‘)の溶液に鮒‐塩酸(5の‘)
を加え、室温で1.5時間鷹梓後、減圧下溶媒を蟹去す
る。The solvent was removed under reduced pressure, and the residue was extracted twice with ethyl acetate.
After washing the extract with water and drying, the solvent was distilled off to give a red oily 2-methyl-41 (2-trifluoromethylphenyl)-16-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (4.2 evening). Infrared absorption spectrum (Nujol) 3350, 1700, 16
40, 1605, 1480, 1370, 130 & 120
110QI03F950763 arc-1 nuclear magnetic resonance absorption spectrum (6, CDC130D20) 1,2 (dark blue, t
, J=7HZ), 2.4 (3 days, s), 3-92-4-
38 (Yamahi, m), 5-72 (IH, S), 7.06 (
IH, s), 7.24-7.62 (4th, m) [6]
2-methyl-4-1 (2-chloro-5-nitrophenyl)
-6-diethoxymethyl-1,4-dihydropyridine-
Carp-hydrochloric acid (5') in a solution of 3,5-dicarboxylic acid diethyl ester (5,45') acetone (54,5')
After stirring at room temperature for 1.5 hours, the solvent was removed under reduced pressure.
銭隆に水を加え15分間放置すると結晶が析出する。こ
の結晶を炉取し水洗、乾燥後nーヘキサンと酢酸エチル
の涙液から再結晶つるとmp172−173こ○の2−
メチル−4−(2ークロロ−5−ニトロフエニル)一6
−ホルミルー1・4ージヒドロピリジンー3・5−ジカ
ルボン酸ジェチルェステルの結晶(347の9)を得る
。【71 実施例2一‘11と同様にして、2−メチル
−4一(2ーニトロフエニル)−5ーエトキシカルボニ
ル一6−ジエトキシメチル−1・4−ジヒドロピリジン
ー3−カルボン酸の2−ェトキシエチルエステル(1.
9夕)、アセトン(19叫)および磯−塩酸(1.9の
‘)からmpl07−10がCの2ーメチル−4−(2
ーニトロフエニル)一5ーエトキシカルポニル−6−ホ
ルミル−1・4ージヒドロピリジン−3−カルボン酸の
2−ェトキシェチルェステルの結晶(ジイソプロピルェ
ーテルから再結晶)を得る。If you add water to Qianlong and leave it for 15 minutes, crystals will precipitate. The crystals were taken out of the oven, washed with water, dried, and then recrystallized from a tear solution of hexane and ethyl acetate.
Methyl-4-(2-chloro-5-nitrophenyl)-6
- Obtain crystals of formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (9 of 347). [71 In the same manner as in Example 2-11, 2-ethoxy of 2-methyl-4-(2nitrophenyl)-5-ethoxycarbonyl-6-diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid Ethyl ester (1.
2-methyl-4-(2
Crystals of 2-ethoxychetyl ester of (nitrophenyl)-5-ethoxycarponyl-6-formyl-1,4-dihydropyridine-3-carboxylic acid (recrystallized from diisopropyl ether) are obtained.
【81実施例2−【51と同様にして、2ーメチル−4
一(2ーニトロフエニル)一5−エトキシカルポニル−
6−ジエトキシメチルー1・4ージヒドロピリジン−3
ーカルボン酸の2ーベンジルオキシヱチルエステル(2
.5夕)、アセトン(25の‘)および鮒‐塩酸(2の
‘)から赤色油状の2−メチル−4−(2ーニトロフエ
ニル)−5ーエトキシカルボニル−6−ホルミル−1・
4−ジヒドロピリジンー3−カルボン酸の2ーベンジル
オキシェチルェステル(2.05夕)を得る。[81 Example 2-[2-methyl-4]
-(2-nitrophenyl)-5-ethoxycarponyl-
6-diethoxymethyl-1,4-dihydropyridine-3
-2-benzyloxyethyl ester of carboxylic acid (2
.. 5), acetone (25') and carp-hydrochloric acid (2') to give a red oil of 2-methyl-4-(2nitrophenyl)-5-ethoxycarbonyl-6-formyl-1.
2-benzyloxyethyl ester of 4-dihydropyridine-3-carboxylic acid (2.05 hours) is obtained.
赤外線吸収スペクトル(フィルム)
3380、1695、1532、1485、1277、
1210、110リ1040860750肌‐1核磁気
共鳴吸収スペクトル(6、CDC13)2‐40(知日
、S>、4‐48く2日、S>、6‐〇8(IH、s)
、10.40(IH、s)【91 2ーメチル−4一(
3ーニトロフエニル)一5ーエトキシカルボニル一6−
ジヱトキシメチルー1・4ージヒドロピリジン−3−力
ルボン酸の2‐ェトキシェチルェステル(5.85のの
ァセトン(60泌)の溶液に鮒−塩酸(3M)を加え、
室温で約2時間櫨拝する。Infrared absorption spectrum (film) 3380, 1695, 1532, 1485, 1277,
1210, 110 Ri 1040860750 Skin-1 Nuclear Magnetic Resonance Absorption Spectrum (6, CDC13) 2-40 (Chihito, S>, 4-48 2 days, S>, 6-〇8 (IH, s)
, 10.40 (IH, s) [91 2-methyl-4-(
3-nitrophenyl)-5-ethoxycarbonyl-6-
Add carp-hydrochloric acid (3M) to a solution of 2-ethoxymethyl ester (5.85%) of diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid in acetone (60%),
Boil at room temperature for about 2 hours.
減圧下で溶媒を留去し、銭糟に水を加え、酢酸エチルで
2回抽出する。抽出液を塩化ナトリウム水溶液で洗浄後
溶媒を蟹去すると赤色油状物質(5.7夕)を得る。こ
の油状物質は結晶化する。これをn−へキサンとジェチ
ルェーテルの露液で処理して粉末化し、得られた粉末(
4.81夕)を炉取する。この粉末(1.81夕)をジ
ェチルェーテルと酢酸エチルの混液から再結晶するとm
ploo一101℃の燈黄色粒状晶の2−メチル−4−
(3ーニトロフエニル)一5ーエトキシカルボニル−6
ーホルミルー1・4−ジヒドロピリジンー3−カルボン
酸の2ーェトキシエチルェステル(1.2夕)を得る。
00 2−メチル−4一(3−ニトロフヱニル)−5−
エトキシカルポニル−6−ジエトキシメチル−1・4ー
ジヒドロピリジンー3−力ルボン酸の2一(N−メチル
−N−ペンジルアミノ)エチルエステル(7.25夕)
のアセトン(70叫)の溶液に鮒−塩酸(7の‘)を加
え、室温で3時間渡洋する。減圧下で溶媒を蟹去し、残
澄に水を加えると油状物質が分離する。重炭酸ナトリウ
ムの粉末を添加して液性をアルカリ性に調整し、酢酸エ
チルで抽出する。抽出液を水洗乾燥後溶媒を留去すると
赤色油状の2ーメチルー4一(3ーニトロフヱニル)一
5−ヱトキシカルボニル−6ーホルミル−1・4−ジヒ
ドロピリジンー3ーカルボン酸の2−(N−メチル−N
ーベンジルアミノ)エチルエステル(5.8のを得る。
赤外線吸収スペクトル(フィルム)3350、1735
、1700、1690、1635、1600、1525
、1480、1350、1279、1215、1100
、103u 735又‐1核磁気共鳴吸収スペクトル(
6、CDC13十D20)1.29(9日、t、J =
7日2)、2.21(3日、s)、2.45(9H、s
)、2.63(2日、t、J=6HZ)、3.51(斑
、s)、3.95‐4,42(が、t)、3.95−4
.42(2日、q)、5.28(IH、s)、7.08
(IH、s)、7.28一8.12(4日、m)、10
.54(IH、s)実施例 3
‘1’2ーメチルー4−(2ークロロフエニル)一6ー
ホルミルー1・4ージヒドロピリジンー3・5ージカル
ボン酸ジェチルェステル(377.8の9)、ヒドロキ
シルアミン塩酸塩(83.4の9)および炭酸ナトリウ
ム(63.6の9)のェタ/ール(1の‘)の溶液を室
温で30分間損拝する。The solvent was distilled off under reduced pressure, water was added to the liquid, and the mixture was extracted twice with ethyl acetate. The extract was washed with an aqueous sodium chloride solution and the solvent was removed to give a red oily substance (5.7 hours). This oil crystallizes. This was treated with a dew solution of n-hexane and diethyl ether to powder, and the obtained powder (
4.81 evening) was taken to the oven. When this powder (1.81 evening) was recrystallized from a mixture of diethyl ether and ethyl acetate, m
2-Methyl-4- in light yellow granular crystals at 101°C
(3-nitrophenyl)-5-ethoxycarbonyl-6
-formyl-2-ethoxyethyl ester of 1,4-dihydropyridine-3-carboxylic acid (1.2 hours) is obtained.
00 2-Methyl-4-(3-nitrophenyl)-5-
Ethoxycarponyl-6-diethoxymethyl-1,4-dihydropyridine-3-carboxylic acid 2-(N-methyl-N-pendylamino)ethyl ester (7.25 evening)
Add carp-hydrochloric acid (7') to a solution of acetone (70') and leave at room temperature for 3 hours. The solvent is removed under reduced pressure and water is added to the residue to separate an oily substance. The liquid is made alkaline by adding sodium bicarbonate powder and extracted with ethyl acetate. After washing the extract with water and drying, the solvent was distilled off to give a red oily 2-(N-methyl-N
-benzylamino)ethyl ester (5.8) is obtained.
Infrared absorption spectrum (film) 3350, 1735
, 1700, 1690, 1635, 1600, 1525
, 1480, 1350, 1279, 1215, 1100
, 103u 735-1 nuclear magnetic resonance absorption spectrum (
6, CDC130D20) 1.29 (9th, t, J =
7 days 2), 2.21 (3 days, s), 2.45 (9H, s
), 2.63 (2 days, t, J=6HZ), 3.51 (spots, s), 3.95-4, 42 (ga, t), 3.95-4
.. 42 (2 days, q), 5.28 (IH, s), 7.08
(IH, s), 7.28-8.12 (4th, m), 10
.. 54 (IH, s) Example 3 '1'2-Methyl-4-(2-chlorophenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (9 of 377.8), hydroxylamine hydrochloride (83. A solution of 4 part 9) and sodium carbonate (63.6 part 9) in ethyl alcohol (1 part') is stirred at room temperature for 30 minutes.
反応液を濃縮し、磯澄に水を加えて酢酸エチルで抽出す
る。抽出液を水洗乾燥後濃縮すると黄色油状物質(47
6の夕)を得る。この油状物質をnーヘキサンで処理し
て2ーメチル−4−(2ークロロフエニル)一6ーヒド
ロキシイミノメチルー1・4ージヒドロピリジン−3・
5−ジカルボン酸ジェチルェステルの結晶(318.8
の9)を得、相当する6−シアノ体(mp136一13
7℃)に導いて確認した。‘2) 2ーメチルー4一(
2ークロロフエニル)−6ーホルミルー1−4−ジヒド
ロピリジンー3・5−ジカルボン酸ジェチルェステル(
525.3の9)、0ーメチルヒドロキシルアミン塩酸
塩(139.34の9)および99%エタノール(2の
!)の混合物に炭酸ナトリウム(88.5の9)の水(
1の‘)の溶液を蝿梓下室温で20分を要して滴下し、
さらに10分間燈拝する。The reaction solution is concentrated, water is added to the isosumi, and the mixture is extracted with ethyl acetate. The extract was washed with water, dried, and concentrated to give a yellow oily substance (47
6 evening). This oily substance was treated with n-hexane to produce 2-methyl-4-(2-chlorophenyl)-6-hydroxyiminomethyl-1,4-dihydropyridine-3.
Crystals of 5-dicarboxylic acid diethyl ester (318.8
9) and the corresponding 6-cyano form (mp136-13
7°C) and confirmed. '2) 2-methyl-41 (
2-chlorophenyl)-6-formyl-1-4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (
525.3 in 9), 0-methylhydroxylamine hydrochloride (139.34 in 9) and 99% ethanol (2 in!) in sodium carbonate (88.5 in 9) in water (
The solution of 1) was added dropwise to the fly at room temperature over a period of 20 minutes.
Pray for another 10 minutes.
減圧下で溶媒を留去し、残澄に水を加え、酢酸エチルで
抽出する。抽出液を2回水洗後、塩化ナトリウム飽和水
溶液で洗浄し、硫酸マグネシウムで乾燥した後、減圧下
で濃縮する。得られた油状物質は結晶化する。この結晶
をnーヘキサンで洗浄し得られた粉末(504.6雌)
をnーヘキサン(10部)とジェチルェーテル(1部)
の混液から再結晶するとmpllo−11か0の2−メ
チル−4−(2ークロロフエニル)一6ーメトキシイミ
ノメチルー144ージヒドロピリジンー3・5ージカル
ボン酸ジェチルェステルの黄色粒状晶(301.5の9
)を得る。‘3} 2−メチル−4一(2−トリフルオ
ロメチルフエニル)−6−ホルミルー1・4−ジヒドロ
ピリジンー3・5−ジカルボン酸ジェチルェステル(8
70の9)、ヒドロキシルアミン塩酸塩(147雌)お
よび炭酸ナトリウム(112.1の9)のエタノール(
5の‘)の溶液を室温で30分間境拝する。The solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract is washed twice with water, then with a saturated aqueous solution of sodium chloride, dried over magnesium sulfate, and concentrated under reduced pressure. The oil obtained crystallizes. Powder obtained by washing this crystal with n-hexane (504.6 female)
n-hexane (10 parts) and diethyl ether (1 part)
When recrystallized from a mixed solution of mpllo-11 or 0, yellow granular crystals of 2-methyl-4-(2-chlorophenyl)-16-methoxyiminomethyl-144-dihydropyridine-3,5-dicarboxylic acid diethyl ester (301.5 of 9
). '3} 2-Methyl-4-(2-trifluoromethylphenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (8
70 of 9), hydroxylamine hydrochloride (147 female) and sodium carbonate (112.1 of 9) in ethanol (
Incubate the solution in step 5') at room temperature for 30 minutes.
反応液を濃縮し、残糟に水を加え酢酸エチルで抽出する
。抽出液を塩化ナトリウム飽和水溶液で洗浄し、硫酸マ
グネシウムで乾燥後減圧下で濃縮すると粘鋼性油状物質
(0.992夕)を得る。得られた油状物質を溶出溶媒
(ベンゼン:酢酸エチル=10:1)を用いてシリカゲ
ルカラムクロマトグラフイーに付して精製すると黄色粉
状の2ーメチルー4−(2ートリフルオロメチルフヱニ
ル)一6ーヒドロキシイミノメチルー1・4−ジヒドロ
ピリジンー3・5−ジカルポン酸ジェチルヱステル(0
.52夕)を得る。赤外線吸収スペクトル(ヌジョール
)
3410、1695「 1680、1655、1483
、1445、1370、1309、1221、1106
、1090、1057、1034101Q 98ふ 7
72伽‐1核磁気共鳴吸収スペクトル(6、CDC13
)1.17(細、t、J=7HZ)、1.20(斑、t
、J=7HZ)、2.35(紬、s)、3.8‐4.4
(4日、m)、564(IH、broad s)、6.
91(IH、broad s)、7.2‐7.7(岬、
m)、8.4(IH、broad s)、8.8(IH
、s)(4)2ーメチルー4−(2ートリフルオロメチ
ルフヱニル)一6ーホルミルー114ージヒドロピリジ
ンー315ージカルポン酸ジェチルヱステル(1.23
夕)、ヒドロキシルアミン塩酸塩(250.2脚)のエ
タノール(5の【)の溶液に炭酸ナトリウム(190.
&9)の水(1.5の‘)の溶液を加え、室温で30分
間燈拝する。The reaction solution was concentrated, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract is washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure to give a viscous oil (0.992 mm). The obtained oily substance was purified by silica gel column chromatography using an eluent (benzene: ethyl acetate = 10:1) to obtain 2-methyl-4-(2-trifluoromethylphenyl) as a yellow powder. 1-6-hydroxyiminomethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (0
.. 52 evening). Infrared absorption spectrum (Nujol) 3410, 1695 "1680, 1655, 1483
, 1445, 1370, 1309, 1221, 1106
, 1090, 1057, 1034101Q 98fu 7
72ka-1 nuclear magnetic resonance absorption spectrum (6, CDC13
) 1.17 (fine, t, J=7HZ), 1.20 (spotted, t
, J=7HZ), 2.35 (Pongee, s), 3.8-4.4
(4th day, m), 564 (IH, broad s), 6.
91 (IH, broad s), 7.2-7.7 (Misaki,
m), 8.4 (IH, broad s), 8.8 (IH
, s) (4) 2-methyl-4-(2-trifluoromethylphenyl)-6-formyl-114-dihydropyridine-315-dicarboxylic acid diethyl ester (1.23
evening), add sodium carbonate (190.2 mm) to a solution of hydroxylamine hydrochloride (250.2 mm) in ethanol (5).
Add a solution of &9) water (1.5') and incubate for 30 minutes at room temperature.
反応液を濃縮し、残澄に水を加え酢酸エチルで抽出する
。抽出液を塩化ナトリウム飽和水溶液で洗浄し、硫酸マ
グネシウムで乾燥後減圧下で濃縮すると油状物質を得る
。この油状物質をn−へキサンで処理して結晶化すると
2ーメチル−4−(2ートリフルオロメチルフエニル)
一6−ヒドロキシイミノメチル−1・4ージヒドロピリ
ジン−3・5−ジカルポン酸ジェチルェステルの結晶(
1.09夕)を得る。(5) 2ーメチルー4−(3ー
ニトロフエニル)一5−エトキシカルボニル−6ーホル
ミルー114−ジヒドロピリジン−3−カルボン酸の2
−(N−メチル−Nーベンジルアミノ)エチルエステル
(1.015夕)、ヒドロキシルアミン塩酸塩(116
.8の9)およびエタノール(3泌)の混合物に炭酸ナ
トリウム(127.2の9)の水(1の‘)の溶液を徐
々に滴下し、室温で50分間縄拝する。The reaction solution was concentrated, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract is washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure to give an oil. When this oily substance is treated with n-hexane and crystallized, it produces 2-methyl-4-(2-trifluoromethylphenyl).
Crystals of 1-6-hydroxyiminomethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (
1.09 evening). (5) 2-methyl-4-(3nitrophenyl)-5-ethoxycarbonyl-6-formyl-114-dihydropyridine-3-carboxylic acid 2
-(N-methyl-N-benzylamino)ethyl ester (1.015 m), hydroxylamine hydrochloride (116 m)
.. A solution of sodium carbonate (127.2, 9) and water (1, 1) was gradually added dropwise to a mixture of 8, 9) and ethanol (3), and the mixture was incubated at room temperature for 50 minutes.
減圧下で反応液を濃縮し、残澄に水を加え酢酸エチルで
抽出する。抽出液を塩化ナトリウム水溶液で洗浄し乾燥
後減圧下で濃縮すると黄色油状の2ーメチルー4一(3
ーニトロフェニル)一5ーエトキシカルボニル一6ーヒ
ドロキシイミノメチルー1・4−ジヒドロピリジン−3
−カルボン酸の2−(NーメチルーN−ペンジルアミノ
)エチルェステル(1.01夕)を得る。赤外線吸収ス
ペクトル(フィルム)3350、1690、1460、
1375、1私8、1205、10双〆1044 73
〆 72い 700伽‐1核磁気共鳴吸収スペクトル(
6、CDC13)1.22(斑、t、J:7HZ)、2
,26(畑、s)、2.36(細、s)、2.70(が
、t、J=6HZ)、3.斑(餌、s)、4.09(餌
、q、J=7HZ)、4.18(が、t、J=6HZ)
、5.14(IH、s)、7.1‐8.1(1岬、m)
、8.97(IH、S)【61 前記実施例3−{11
〜3−■と同様にして、次の化合物を得る。The reaction solution was concentrated under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract was washed with an aqueous sodium chloride solution, dried, and concentrated under reduced pressure to yield a yellow oily 2-methyl-4-(3
(nitrophenyl)-5-ethoxycarbonyl-6-hydroxyiminomethyl-1,4-dihydropyridine-3
2-(N-methyl-N-pendylamino)ethyl ester of -carboxylic acid (1.01 min.) is obtained. Infrared absorption spectrum (film) 3350, 1690, 1460,
1375, 1 I8, 1205, 10 pair 1044 73
〆 72 700 Ka-1 Nuclear Magnetic Resonance Absorption Spectrum (
6, CDC13) 1.22 (spot, t, J:7HZ), 2
, 26 (field, s), 2.36 (thin, s), 2.70 (ga, t, J=6HZ), 3. Spot (bait, s), 4.09 (bait, q, J=7HZ), 4.18 (ga, t, J=6HZ)
, 5.14 (IH, s), 7.1-8.1 (1 Cape, m)
, 8.97 (IH, S) [61 Said Example 3-{11
The following compound is obtained in the same manner as in ~3-■.
(1} 2ーメチル−4−(2−ニトロフエニル)−6
ーヒドロキシイミノメチルー1・4−ジヒドロピリジン
−3・5−ジカルボン酸ジェチルヱステル(2’ 2ー
メチルー4一(2ークロロー5−ニトロフエニル)一6
−ヒドロキシイミノメチルー1・4−ジヒドロピリジン
ー3・5ージカルボン酸ジェチルェステル士3} 2ー
メチルー4一(3−ニトロフエニル)一5ーエトキシカ
ルボニル−6ーヒドロキシイミノメチルー1・4ージヒ
ドロピリジン−3−カルボン酸の2−ェトキシェチルェ
ステノレこれら側一【1ー〜糊の化合物はそれぞれ相当
する6ーシアノ体に導いて確認した。(1} 2-methyl-4-(2-nitrophenyl)-6
-Hydroxyiminomethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethylester (2' 2-methyl-4-(2-chloro-5-nitrophenyl)-6
-Hydroxyiminomethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-hydroxyiminomethyl-1,4-dihydropyridine-3-carvone The 2-ethoxycetyl ester compounds of the acid were confirmed by converting them into the corresponding 6-cyano compounds.
実施例 4 (1’一【11 2−メチル一4一(2−ク。Example 4 (1'1 [11 2-methyl-41 (2-k.
ロフエニル)一6−ヒドロキシイミノメチル−1・4−
ジヒドロピリジン−3・5−ジカルボン酸ジエチルエス
テル(0.6135夕)、N・N′ージシクロヘキシル
カルボジイミド(804.6雌)およびピリジン(3泌
)の混合物を6時間加熱還流する。反応液を希塩酸で酸
性にし酢酸エチルで抽出する。析出する不溶物質を炉去
し、炉液を水洗後硫酸マグネシウムで乾燥する。減圧下
で溶媒を蟹去し、残澄にジェチルェーテルを加え炉遇す
る。炉液を減圧下で濃縮し得られた赤色油状物質(70
3.7の9)を溶出溶媒(ベンゼン:酢酸エチル=10
:1)を用いてシリカゲルカラムクロマトグラフイーに
付して精製しnーヘキサンで処理して結晶化する。得ら
れた結晶をn−へキサンおよびジェチルェーテルの混液
から再結晶するとmp136一137℃の2−メチル−
4一(2ークロロフエニル)−6ーシアノー1・4−ジ
ヒドロピリジンー3・5ージカルポン酸ジェチルェステ
ルの黄色結晶(417.1の3)を得る。(lofenyl)-6-hydroxyiminomethyl-1,4-
A mixture of dihydropyridine-3,5-dicarboxylic acid diethyl ester (0.6135 mm), N.N'-dicyclohexylcarbodiimide (804.6 mm) and pyridine (3 mm) is heated to reflux for 6 hours. The reaction solution was made acidic with dilute hydrochloric acid and extracted with ethyl acetate. The precipitated insoluble substances are removed from the furnace, and the furnace solution is washed with water and dried over magnesium sulfate. The solvent was removed under reduced pressure, and diethyl ether was added to the residue and heated. A red oily substance obtained by concentrating the furnace liquid under reduced pressure (70
3.7-9) with elution solvent (benzene: ethyl acetate = 10
:1) and purified by silica gel column chromatography and crystallized by treatment with n-hexane. When the obtained crystals are recrystallized from a mixture of n-hexane and diethyl ether, mp136-2-methyl-
Yellow crystals (417.1-3) of 4-(2-chlorophenyl)-6-cyano 1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester are obtained.
【1}−■ 2ーメチルー4−(2−クロロフエニル)
一6ーホルミル−1・4ージヒドロピリジンー3・5ー
ジカルボン酸ジェチルェステル(377.8雌)、義酸
ナトリウム(125雌)、ヒドロキシルアミン塩酸塩(
79.93の9)および義酸(1.5の‘)の混合物を
1時間加熱還流する。反応液に水を加え、酢酸エチルで
抽出し、不溶物を炉去する。[1}-■ 2-methyl-4-(2-chlorophenyl)
1-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (377.8 females), sodium chloride (125 females), hydroxylamine hydrochloride (
A mixture of 79.93 of 9) and odoric acid (1.5 of) is heated to reflux for 1 hour. Water was added to the reaction solution, extracted with ethyl acetate, and insoluble matter was removed in an oven.
炉液を水、重炭酸ナトリウム、水次いで塩化ナトリウム
飽和水溶液で順次洗浄後硫酸マグネシウムで乾燥し、溶
媒を蟹去する。残澄にジェチルェーテルを加え、不溶粉
末を炉取し、炉液を減圧下で濃縮する。得られた油状物
質(210の9)をn−へキサンとジヱチルェーテルの
混液で処理すると2−メチル−4−(2ークロロフエニ
ル)一6−シアノー1・4ージヒドロピリジンー3・5
−ジカルボン酸ジェチルェステルの結晶(154.1の
9)を得る。The filtrate was washed successively with water, sodium bicarbonate, water and then a saturated aqueous solution of sodium chloride, dried over magnesium sulfate, and the solvent was removed. Diethyl ether is added to the residual liquid, the insoluble powder is removed by a furnace, and the furnace liquid is concentrated under reduced pressure. When the obtained oily substance (9 of 210) is treated with a mixture of n-hexane and diethyl ether, 2-methyl-4-(2-chlorophenyl)-6-cyano-1,4-dihydropyridine-3,5 is obtained.
- Obtain crystals of dicarboxylic acid diethyl ester (9 of 154.1).
このものは標品により同定した。{11一(31 2−
メチル−4一(2ークロロフエニル)−6ーホルミルー
1・4ージヒドロピリジン−3・5−ジカルボン酸ジェ
チルェステル(377.8の2)、義酸ナトリウム(1
25の9)、ヒドロキシルアミン塩酸塩(79.93の
9)および義酸(1.5の【)の混合物を室温で5分間
燈拝した後無水酢酸(0.2のこ)を加え室温で20分
間擬拝、次いで1時間加熱還流する。This substance was identified using a specimen. {11-(31 2-
Methyl-4-(2-chlorophenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (377.8-2), sodium dinate (1
After heating a mixture of 25-9), hydroxylamine hydrochloride (79.93-9) and sulfuric acid (1.5 [)] at room temperature for 5 minutes, acetic anhydride (0.2) was added and the mixture was heated at room temperature. Stir for 20 minutes, then heat under reflux for 1 hour.
反応液に水を加え、酢酸エチルで抽出する。抽出液を重
炭酸ナトリウム水溶液、水次いで塩化ナトリウム飽和水
溶液で順次洗浄し、硫酸マグネシウムで乾燥後減圧下で
濃縮する。得られた褐色油状物質(0.41夕)をジェ
チルェーテルとn−へキサンの混液で処理すると黄色粉
状の2ーメチルー4−(2−クロロフェニル)一6ーシ
アノー1・4ージヒドロピリジン−305ージカルポン
酸ジェチルェステル(207雌)を得る。Add water to the reaction solution and extract with ethyl acetate. The extract is washed successively with aqueous sodium bicarbonate solution, water and saturated aqueous sodium chloride solution, dried over magnesium sulfate and concentrated under reduced pressure. When the obtained brown oily substance (0.41 μm) is treated with a mixture of diethyl ether and n-hexane, a yellow powder of 2-methyl-4-(2-chlorophenyl)-16-cyano-1,4-dihydropyridine-305-dicarboxylic acid diethyl ester is obtained. (207 females) were obtained.
このものは標品により同定した。{1)−{4) 2−
メチル−4一(2ークロロフエニル)一6ーホルミル−
104ージヒドロピリジンー305ージカルボン酸ジェ
チルェステル(377.8双9)、酢酸ナトリウム(1
64の9)、ヒドロキシルアミン塩酸塩(80の9)お
よび酢酸(1.5の‘)の混合物を室温で30分間鷹拝
した後、無水酢酸(0.2舷)を加え、室温で1時間損
梓次いでさらに1時間加熱還流する。This substance was identified using a specimen. {1)-{4) 2-
Methyl-4-(2-chlorophenyl)-6-formyl-
104-dihydropyridine-305-dicarboxylic acid diethyl ester (377.8 double 9), sodium acetate (1
A mixture of 64-9), hydroxylamine hydrochloride (80-9) and acetic acid (1.5') was stirred at room temperature for 30 minutes, then acetic anhydride (0.2) was added and the mixture was stirred at room temperature for 1 hour. The mixture is then heated under reflux for an additional hour.
反応液に水を加え、酢酸エチルで抽出し、抽出液を水、
重炭酸ナトリウム水溶液次いで水で順次洗浄後硫酸マグ
ネシウムで乾燥し、減圧下で濃縮する。得られた黄色油
状物質(410の9)をnーヘキサンで処理すると2ー
メチルー4一(2ークロロフエニル)−6−シアノー1
04−ジヒドロピリジン−315−ジカルボン酸ジェチ
ルヱステルの結晶(342.4の9)を得る。このもの
は標品により同定した。■ 2ーメチルー4−(2ーニ
トロフエニル)一6−ホルミルーIQ4ージヒドロピリ
ジン−3・5−ジカルボン酸ジェチルェステル(2.0
3夕)、酢酸ナトリウム(861.4の9)、ヒドロキ
シルアミン塩酸塩(417雌)および酢酸(15の【)
の混合物を室温で30分間蝿拝した後、無水酢酸(1の
‘)を加え、室温で90分間鷹伴次いでさらに1時間加
熱還流する。Water was added to the reaction solution, extracted with ethyl acetate, and the extract was diluted with water and
After washing successively with aqueous sodium bicarbonate and then water, dry over magnesium sulfate and concentrate under reduced pressure. When the obtained yellow oily substance (9 of 410) was treated with n-hexane, 2-methyl-4-(2-chlorophenyl)-6-cyano1
Crystals of diethylester 04-dihydropyridine-315-dicarboxylate (342.4-9) are obtained. This substance was identified using a specimen. ■ 2-Methyl-4-(2nitrophenyl)-6-formyl-IQ4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (2.0
3 evenings), sodium acetate (9 of 861.4), hydroxylamine hydrochloride (417 females) and acetic acid (15 of [)]
After the mixture was stirred at room temperature for 30 minutes, acetic anhydride (1') was added, and the mixture was heated at room temperature for 90 minutes and then heated under reflux for an additional hour.
減圧下で酢酸を蟹去しも反応液に水を加え、重炭酸ナト
リウムでpH7に調整した後ジェチルェーテルで抽出す
る。抽出液を水洗し、硫酸マグネシウムで乾燥した後減
圧下で濃縮する。得られた油状物質を溶出溶媒(ベンゼ
ン:酢酸エチル=4:1)を用いてシリカゲルカラムク
ロマトグラフイーに付す。得られた油状物質(1.7夕
)をジェチルェーテルとnーヘキサンの混液で処理して
得られた結晶(1.5夕)をジェチルェーテルとnーヘ
キサンの混液から再結晶するとmp126−127.5
℃の2ーメチルー4一(2ーニトロフエニル)一6ーシ
アノー1・4−ジヒドロピリジンー315ージカルボン
酸ジェチルェステルの結晶(1.23多)を得る。【3
}一【11 2−メチル一4一(2−トリフルオロメチ
ルフエニル)一6ーヒドロキシイミノメチル−114ー
ジヒドロピリジンー3・5ージカルボン酸ジェチルヱス
テル(0.49夕)およびチオニルクロラィド(1.5
の‘)の乾燥ジェチルェーテル(1.5の‘)の溶液を
室温で30分間礎拝する。After removing the acetic acid under reduced pressure, water was added to the reaction mixture, the pH was adjusted to 7 with sodium bicarbonate, and the mixture was extracted with diethyl ether. The extract is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. The obtained oily substance is subjected to silica gel column chromatography using an elution solvent (benzene:ethyl acetate=4:1). When the obtained oily substance (1.7 night) was treated with a mixture of diethyl ether and n-hexane and the crystals obtained (1.5 night) were recrystallized from a mixture of diethyl ether and n-hexane, mp126-127.5 was obtained.
Crystals (1.23 poly) of 2-methyl-4-(2-nitrophenyl)-6-cyano-1,4-dihydropyridine-315-dicarboxylic acid diethyl ester are obtained at a temperature of 1.23 °C. [3
}1[11 2-Methyl-4-(2-trifluoromethylphenyl)-6-hydroxyiminomethyl-114-dihydropyridine-3,5-dicarboxylic acid diethyl ester (0.49 m) and thionyl chloride (1. 5
Incubate a solution of dry diethyl ether (1.5') for 30 min at room temperature.
反応液を濃縮し、残澄に水を加えた後、酢酸エチルで抽
出する。抽出液を水洗後「硫酸マグネシウムで乾燥し、
減圧下で濃縮する。得られた油状物質(0.39夕)を
溶出溶媒(ベンゼン:酢酸エチル=5三1)を用いてシ
リカゲルカラムクロマトグラフイーに付して精製し、次
いでn−へキサンで処理して黄色粉末(50の2)を得
る。これをジェチルェーテルとnーヘキサンの混液から
再結晶するとmp140−143こCの2−メチル−4
−(2ートリフルオロメチルフエニル)一6−シアノー
104ージヒドロピリジンー3・5ージカルボン酸ジェ
チルェステルの結晶を得る。【3’一‘21 2ーメチ
ル−4−(2ートリフルオロメチルフエニル)一6ーホ
ルミル−114ージヒドロピリジン−315−ジカルボ
ン酸ジェチルエステル(1.09多)、N・N′ージシ
クロヘキシルカルボジイミド(1.319夕)およびピ
リジン(5肌【)の混合物を6.5時間加熱還流する。The reaction solution is concentrated, water is added to the residue, and then extracted with ethyl acetate. After washing the extract with water, dry it with magnesium sulfate,
Concentrate under reduced pressure. The obtained oil (0.39 mm) was purified by silica gel column chromatography using an eluent (benzene: ethyl acetate = 5:1), and then treated with n-hexane to give a yellow powder. (2 of 50) is obtained. When this is recrystallized from a mixture of diethyl ether and n-hexane, mp140-143 is 2-methyl-4 of C.
Crystals of -(2-trifluoromethylphenyl)-6-cyano-104-dihydropyridine-3,5-dicarboxylic acid diethyl ester are obtained. [3'-1'21 2-Methyl-4-(2-trifluoromethylphenyl)-6-formyl-114-dihydropyridine-315-dicarboxylic acid diethyl ester (1.09 poly), N・N'-dicyclohexylcarbodiimide ( A mixture of 1.319 minutes) and pyridine (5 hours) is heated to reflux for 6.5 hours.
ピリジンを留去後、孫澄に希塩酸を加え10分間蝿拝し
た後酢酸エチルで抽出する。不溶物を炉去し、炉液を水
洗後硫酸マグネシウムで乾燥し減圧下で濃縮する。得ら
れた褐色油状物質(1.09夕)を溶出溶媒(ベンゼン
:酢酸エチル=10:1)を用いてシリカゲルカラムク
ロマトグラフィーを用いて精製し、nーヘキサンで処理
して結晶化する。析出物を炉取し、nーヘキサンで洗浄
した後、得られた黄色粉末(610の9)をジェチルェ
ーテルとnーヘキサンの濠液から再結晶するとmp14
0−14300の2−メチル−4一(2−トリフルオロ
メチルフエニル)−6−シアノー114ージヒドロピリ
ジン−3・5ージカルボン酸ジェチルェステルの結晶を
得る。(3’一【3} 2−メチル一4一(2−トリフ
ルオロメチルフエニル)−6−ホルミル−1・4−ジヒ
ドロピリジン−3・5−ジカルボン酸ジェチルヱステル
(205.7のo)、酢酸ナトリウム(82雌)、ヒド
ロキシルアミン塩酸塩(40の9)および酢酸(1.5
の【)の混合物を室温で30分間蝿拝した後、無水酢酸
(0.1M)を加え、室温で1.虫時間燈拝次いでさら
に1時間加熱還流する。After distilling off the pyridine, dilute hydrochloric acid was added to the mixture, stirred for 10 minutes, and then extracted with ethyl acetate. Insoluble materials are removed from the furnace, and the furnace solution is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. The obtained brown oil (1.09 pm) is purified by silica gel column chromatography using an eluent (benzene: ethyl acetate = 10:1) and crystallized by treatment with n-hexane. After collecting the precipitate in a furnace and washing it with n-hexane, the obtained yellow powder (9 of 610) was recrystallized from a solution of diethyl ether and n-hexane, resulting in mp14.
Crystals of 2-methyl-4-(2-trifluoromethylphenyl)-6-cyano-114-dihydropyridine-3,5-dicarboxylic acid diethyl ester of 0-14300 are obtained. (3'-[3} 2-methyl-4-1(2-trifluoromethylphenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (205.7 o), sodium acetate (82 females), hydroxylamine hydrochloride (9 of 40) and acetic acid (1.5
After the mixture of [) was stirred at room temperature for 30 minutes, acetic anhydride (0.1M) was added, and the mixture was stirred at room temperature for 1. After heating for an hour, the mixture was heated under reflux for an additional hour.
反応液に水を加え、酢酸エチルで抽出し、抽出液を水、
重炭酸ナトリウム水溶液次いで水で順次洗浄後硫酸マグ
ネシウムで乾燥し、減圧下で濃縮する。得られた油状物
質(201雌)を溶出溶媒(ベンゼン:酢酸エチル=5
:1)を用いてシリカゲルカラムクロマトグラフィーに
付して精製し、得られた油状物質(172.4の9)を
nーヘキサンで処理すると2−メチル−4−(2ートリ
フルオロメチルフエニル)−6−シアノ−1・4−ジヒ
ドロピリジン−3・5ージカルボン酸ジェチルェステル
の粉末(11&9)を得る。このものを標品により同定
した。【4,2−メチル一4一(2ークロロー5ーニト
ロフエニル)一6−ホルミルー1・4ージヒドロピリジ
ン−315ージカルボン酸ジェチルェステル(3.70
夕)、酢酸ナトリウム(1.436夕)、ヒドロキシル
アミン塩酸塩(695級)および酢酸(36の【)の混
合物を室温で2.5時間燈拝した後、無水酢酸(2の【
)を加え、室温で30分間渡拝次いでさらに1.5時間
加熱還流する。Water was added to the reaction solution, extracted with ethyl acetate, and the extract was diluted with water and
After washing successively with aqueous sodium bicarbonate and then water, drying over magnesium sulfate and concentrating under reduced pressure. The obtained oily substance (201 female) was dissolved in an elution solvent (benzene: ethyl acetate = 5
:1) was purified by silica gel column chromatography, and the obtained oily substance (9 of 172.4) was treated with n-hexane to yield 2-methyl-4-(2-trifluoromethylphenyl). -6-cyano-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester powder (11 & 9) is obtained. This substance was identified using a standard specimen. [4,2-Methyl-4-(2-chloro-5-nitrophenyl)-6-formyl-1,4-dihydropyridine-315-dicarboxylic acid diethyl ester (3.70
After heating a mixture of sodium acetate (1.436 mm), hydroxylamine hydrochloride (695 grade) and acetic acid (36 [)] at room temperature for 2.5 hours, acetic anhydride (2 [
), stirred at room temperature for 30 minutes, and heated under reflux for an additional 1.5 hours.
酢酸を留去した後、残笹に水および酢酸エチルを加え、
希重炭酸ナトリウム水溶液で2回、次いで塩化ナトリウ
ム水溶液で洗浄後硫酸マグネシウムで乾燥し、減圧下で
濃縮する。残澄にジエチルェーテルを加え、得られた粉
末(2.5夕)を溶出溶媒(ベンゼン:酢酸エチル=1
0:1)を用いてシリカゲルカラムクロマトグラフイー
に付す。溶出液について、薄層クロマトグラフィーで1
スポットを示すフラクションを濃縮して得られた結晶(
450の9)と複数のスポットを示すフラクションを濃
縮して得られた結晶(1.0夕)を合し、ベンゼンと酢
酸エチルの混液から再結晶するとmp204.5一20
5.90の2ーメチルー4一(2−クロロ−5ーニトロ
フエニル)−6−シアノ−1・4−ジヒドロピリジンー
3・5ュジカルボソ酸ジェチルェステルの結晶(657
の9)を得る。(5’一‘1)2−メチル一4一(3ー
ニトロフエニル)−5−エトキシカルボニル−6−ヒド
ロキシイミノメチルー1・4ージヒドロピリジン−3−
カルポン酸の2−(Nーベンジル−Nーメチルアミノ)
エチルエステル(0.91夕)、N・N′ージシクロヘ
キシルカルボジイミド(0.職7夕)およびピリジン(
5の【)の混合液を室温で3時間加熱還流する。After distilling off the acetic acid, water and ethyl acetate were added to the remaining bamboo,
After washing twice with dilute aqueous sodium bicarbonate solution and then with aqueous sodium chloride solution, dry over magnesium sulfate and concentrate under reduced pressure. Diethyl ether was added to the residue, and the resulting powder (2.5 hours) was mixed with an elution solvent (benzene: ethyl acetate = 1
0:1) and subjected to silica gel column chromatography. Regarding the eluate, 1
Crystals obtained by concentrating the fraction showing spots (
9) of 450 and the crystals obtained by concentrating the fraction showing multiple spots (1.0 m) were combined and recrystallized from a mixture of benzene and ethyl acetate to obtain mp204.5-20.
Crystals of 2-methyl-4-(2-chloro-5-nitrophenyl)-6-cyano-1,4-dihydropyridine-3,5-dicarbosic acid diethyl ester of 5.90 (657
9) is obtained. (5'1'1)2-Methyl-4-1(3-nitrophenyl)-5-ethoxycarbonyl-6-hydroxyiminomethyl-1,4-dihydropyridine-3-
Carboxylic acid 2-(N-benzyl-N-methylamino)
Ethyl ester (0.91 min), N-N'-dicyclohexylcarbodiimide (0.7 min) and pyridine (
The mixture of [) in step 5 is heated under reflux at room temperature for 3 hours.
減圧下でビリジンを蟹去した後、残澄に水を加え酢酸エ
チルで抽出する。不落物を炉去し、炉液を水洗後硫酸マ
グネシウムで乾燥し、減圧下で濃縮する。得られた赤色
油状物質(1.6夕)を溶出溶媒(ベンゼン:酢酸エチ
ル=2:1)を用いてシリカゲルカラムクロマトグラフ
ィーに付して精製すると赤色油状の2ーメチル−4−(
3ーニトロフヱニル)一5ーエトキシカルボニル一6ー
シアノー1・4−ジヒドロピリジン−3−カルボン酸の
2−(N−ペンジル−N−メチルアミノ)エチルェステ
ル(0.脇多)を得る。After removing pyridine under reduced pressure, water was added to the residue and extracted with ethyl acetate. The unfiltered substances are removed from the furnace, and the furnace liquid is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. The obtained red oily substance (1.6 days) was purified by silica gel column chromatography using an eluent (benzene: ethyl acetate = 2:1) to give a red oily 2-methyl-4-(
2-(N-penzyl-N-methylamino)ethyl ester (0.Wakita) of 3-nitrophenyl)-5-ethoxycarbonyl-6-cyano 1,4-dihydropyridine-3-carboxylic acid is obtained.
赤外線吸収スペクトル(ヌジョール)
3320、3250(sh)、2240、1708、1
685、1525、1500、1345、1293、1
210、1100、103078い73ふ700伽‐1
核磁気共鳴吸収スペクトル(6、CDC13)1,25
(班、t、J=7HZ)、2,15(細、s)、2.3
9(紺、s)、2.62(が、t、J=7HZ)、3.
48(が、s)、3.9‐4.3(虻、q(CH2Cは
)、t(COOCH2C比N))、5.26(IH、s
)、7.1‐8.2(1岬、m)上記で得られた化合物
をジェチルヱーテルに溶解した溶液に、ェタ/ール性塩
酸を加え濃縮する。Infrared absorption spectrum (Nujol) 3320, 3250 (sh), 2240, 1708, 1
685, 1525, 1500, 1345, 1293, 1
210, 1100, 103078i73fu700ka-1
Nuclear magnetic resonance absorption spectrum (6, CDC13) 1,25
(Group, t, J=7HZ), 2,15 (thin, s), 2.3
9 (dark blue, s), 2.62 (but, t, J=7HZ), 3.
48 (ga, s), 3.9-4.3 (fly, q (CH2C), t (COOCH2C ratio N)), 5.26 (IH, s
), 7.1-8.2 (1 Cape, m) Add ethyl hydrochloric acid to a solution of the compound obtained above dissolved in diethyl ether and concentrate.
残澄をnーヘキサンで粉末化し、粉末を炉取する。これ
を水性エタノールから再結晶するとmp228−229
00の2−メチル−4−(3−ニトロフヱニル)一5−
エトキシカルボニル−6ーシア/−1・4ージヒドロピ
リジンー3−カルボン酸の2一(NーベンジルーN−メ
チルアミノ)エチルエステルの塩酸塩の黄色結晶(46
0.&9)を得る。【51一脚 2ーメチル−4一(3
−ニトロフエニル)一5ーエトキシカルボニル−6ーホ
ルミル−1・4−ジヒドロピリジンー3−力ルポン酸の
2−(NーベンジルーN−メチルフェニルアミノ)エチ
ルェステル(253.8のp)、酢酸ナトリウム(82
の9)、ヒドロキシルアミン塩酸塩(40のo)および
酢酸(1の【)の混合物を室温で30分間蝿拝した後、
無水酢酸(0.1の‘)を加え、室温で1時間縄梓次い
でさらに1時間加熱還流する。反応液に水を加え、重炭
酸ナトリウムで中和した後酢酸エチルで抽出する。抽出
液を重炭酸ナトリウム水溶液次いで水で洗浄後硫酸マグ
ネシウムで乾燥し、減圧下で濃縮すると油状の2−メチ
ル−4−(3ーニトロフエニル)−5ーエトキシカルボ
ニル−6−シアノー104ージヒドロピリジン−3ーカ
ルポン酸の2−(N−ペンジル−Nーメチルアミノ)エ
チルエステル(250雌)を得る。このものは標品によ
り同定した。The residual liquid is powdered with n-hexane, and the powder is collected in a furnace. When this is recrystallized from aqueous ethanol, mp228-229
00 2-methyl-4-(3-nitrophenyl)-5-
Yellow crystals (46
0. &9) is obtained. [51 monopod 2-methyl-4-(3
-Nitrophenyl)-5-ethoxycarbonyl-6-formyl-1,4-dihydropyridine-3-benzyl 2-(N-benzyl-N-methylphenylamino)ethyl ester (253.8 p), sodium acetate (82
9) After stirring a mixture of hydroxylamine hydrochloride (40 o) and acetic acid (1) for 30 minutes at room temperature,
Add acetic anhydride (0.1') and stir at room temperature for 1 hour, then heat to reflux for an additional hour. Water was added to the reaction solution, neutralized with sodium bicarbonate, and extracted with ethyl acetate. The extract was washed with an aqueous sodium bicarbonate solution and then with water, dried over magnesium sulfate, and concentrated under reduced pressure to give an oily 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-cyano-104-dihydropyridine-3-carpon. The 2-(N-penzyl-N-methylamino)ethyl ester of the acid (250 females) is obtained. This substance was identified using a specimen.
徹 2ーメチルー4一(3ーニトロフヱニル)一5−エ
トキシカルポニルー6−ホルミル−114−ジヒドロピ
リジン−3−カルボン酸の2−ヱトキシェチルェステル
(3。2-ethoxycetyl ester of 2-methyl-4-(3-nitrophenyl)-5-ethoxycarponyl-6-formyl-114-dihydropyridine-3-carboxylic acid (3.
00夕)、酢酸ナトリウム(1.1382夕)、ヒドロ
キシルアミン塩酸塩(0.5547夕)および酢酸(1
0の【)の混合物を室温で30分間蝿拝した後、無水酢
酸(1。00 min), sodium acetate (1.1382 min), hydroxylamine hydrochloride (0.5547 min) and acetic acid (1
A mixture of 0 [)] was stirred at room temperature for 30 minutes, and then acetic anhydride (1.
4の上)を加え、室温で1時間渡梓次いでさらに1時間
加熱還流する。4) was added, stirred at room temperature for 1 hour, and heated under reflux for an additional hour.
減圧下に酢酸を留去した後残澄に水を加え、重炭酸ナト
リウム水溶液で中和し酢酸エチルで抽出する。抽出液を
水、次いで塩化ナトリウム飽和水溶液で洗浄後減圧下で
濃縮する。得られた黄色油状物質を溶出溶媒(ベンゼン
:酢酸エチル=5;1)を用いてシリカゲルカラムクロ
マトグラフイーに付し、目的物質を含有するフラクショ
ンから黄色油状物質(1.74夕)を得る。After acetic acid was distilled off under reduced pressure, water was added to the residue, neutralized with an aqueous sodium bicarbonate solution, and extracted with ethyl acetate. The extract is washed with water and then with a saturated aqueous solution of sodium chloride, and then concentrated under reduced pressure. The obtained yellow oily substance is subjected to silica gel column chromatography using an elution solvent (benzene:ethyl acetate=5:1) to obtain a yellow oily substance (1.74 yen) from the fraction containing the target substance.
この油状物質は結晶(1.56のになる。これをベンゼ
ンから再結晶するとmp89一91℃の2ーメチル−4
−(3−ニトロフエニル)一5ーエトキシカルボニル一
6ーシアノー1・4ージヒドロピリジン−3ーカルボン
酸の2ーェトキシェチルェステル(1/3分子の結晶ベ
ンゼンが付加している)の黄色粉末(1.5夕)を得る
。この粉末をジェチルェーテルおよびn−へキサンの混
液から再結晶するとmpl15皿liがCの2ーメチル
ー4−(3−ニトロフエニル)一5ーエトキシカルボニ
ル一6−シアノ−1・4ージヒドロピリジン−3ーカル
ボン酸の2−ェトキシェチルェステルの結晶を得る。‘
7} 2−メチル一4一(3ーニトロフエニル)一6−
ホルミルー114−ジヒドロピリジン−3・5−ジカル
ボン酸ジェチルヱステル(1.9418夕)、酢酸ナト
リウム(820雌)、ヒドロキシルアミン塩酸塩(39
9.6雌)および酢酸(7.5の‘)の混合物を室温で
30分間燈押した後、無水酢酸(1の‘)を加え、室温
で1時間蝿梓次いでさらに1時間加熱還流する。This oily substance becomes a crystal (1.56). When this is recrystallized from benzene, the mp89-2-methyl-4
Yellow powder (1 .5 evening). When this powder was recrystallized from a mixture of diethyl ether and n-hexane, the mpl15 plateli was converted to 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-cyano-1,4-dihydropyridine-3-carboxylic acid. Crystals of 2-ethoxychetyl ester are obtained. '
7} 2-methyl-41(3-nitrophenyl)-6-
Formyl-114-dihydropyridine-3,5-dicarboxylic acid diethyl ester (1.9418 mm), sodium acetate (820 females), hydroxylamine hydrochloride (39
After heating a mixture of 9.6 mm) and acetic acid (7.5 mm) at room temperature for 30 minutes, acetic anhydride (1 mm) was added, heated at room temperature for 1 hour, and then heated under reflux for an additional hour.
酢酸を蟹去し残澄に水を加え、重炭酸ナトリウム飽和水
溶液で中和した後「析出する油状物質を酢酸エチルで抽
出する。抽出液を塩化ナトリウム水溶液で洗浄後乾燥し
、減圧下で溶媒を蟹去する。得られた燈黄色油状物質(
2.0103夕)は結晶化し、これをジェチルェーテル
、酢酸エチルおよびn−へキサンの鷹液から再結晶する
と黄色粉末を得る。わずかに残存する不純物が混入する
のでこの粉末をベンゼン(5部)および酢酸エチル(1
部)の濠液に溶解し、その溶液をシリカゲルで炉過し炉
液を濃縮する。得られた結晶(1.02多)をベンゼン
およびジエチルヱーテルの混液から再結晶するとmp1
74−177℃の2−メチル−4−(3−ニトロフヱニ
ル)−6ーシアノ−114ージヒドロピリジン−3・5
−ジカルポン酸ジェチルェステルの黄色粒状晶(0.8
479夕)を得る。After removing the acetic acid and adding water to the residue and neutralizing it with a saturated aqueous sodium bicarbonate solution, the precipitated oily substance is extracted with ethyl acetate.The extract is washed with an aqueous sodium chloride solution, dried, and the solvent is removed under reduced pressure. The resulting light yellow oily substance (
2.0103) crystallizes and recrystallizes it from a solution of diethyl ether, ethyl acetate and n-hexane to give a yellow powder. This powder was mixed with benzene (5 parts) and ethyl acetate (1 part) to avoid contamination with a small amount of residual impurities.
The solution is filtered through silica gel and the solution is concentrated. When the obtained crystals (1.02 poly) were recrystallized from a mixture of benzene and diethyl ether, mp1
2-Methyl-4-(3-nitrophenyl)-6-cyano-114-dihydropyridine-3.5 at 74-177°C
- yellow granular crystals of dicarponic acid diethyl ester (0.8
479 evenings).
【8)実施例4−■と同様にして、2−メチル−4−(
2ーニトロフエニル)一5−エトキシカルボニル−6ー
ホルミル−1・4−ジヒドロピリジンー3ーカルボン酸
の2−ペンジルオキシェチルェステル(2.0夕)、酢
酸ナトリウム(662.9の9)、ヒドロキシルアミン
塩酸塩(336.9松9)および酢酸(15泌)の混合
物および無水酢酸(1.5の‘)から結晶(767雌)
を得る。[8] In the same manner as in Example 4-■, 2-methyl-4-(
2-penzyloxyethyl ester of 1-5-ethoxycarbonyl-6-formyl-1,4-dihydropyridine-3-carboxylic acid (2.0), sodium acetate (9 of 662.9), hydroxylamine Crystals (767 females) from a mixture of hydrochloride (336.9 pine 9) and acetic acid (15 chloride) and acetic anhydride (1.5')
get.
これをベンゼンとジェチルェーテルの混液から再結晶す
ると2ーメチルー4一(2−ニトロフェニル)−5ーエ
トキシカルボニル一6ーシアノー1・4−ジヒドロピリ
ジン−3−カルボン酸の2ーベンジルオキシェチルェス
テルの淡黄色結晶(450雌)(さらにジエチルエ−テ
ルとn−へキサンから再結晶するとmp139一140
00)を得る。■ 実施例4一{21と同様にして、2
−メチル一4−(2ーニトロフエニル)−5ーエトキシ
カルボニル−6ーホルミル−1・4−ジヒドロピリジン
−3−カルボン酸の2−ェトキシェチルェステル(90
0雌)、酢酸ナトリウム(乳1倣)、ヒドロキシルアミ
ン塩酸塩(167の9)および酢酸(7泌)の混合物と
無水酢酸(1地)から2ーメチルー4一(2ーニトロフ
エニル)−5ーエトキシカルボニル−6ーシアノー1・
4−ジヒドロピリジンー3−カルボン酸の2ーヱトキシ
Zエチルェステルの結晶(42物9)(ジェチルェーテ
ルとn−へキサンから再結晶してmp129.5一13
0.5qo)を得る。When this was recrystallized from a mixture of benzene and diethyl ether, the 2-benzyloxyethyl ester of 2-methyl-4-(2-nitrophenyl)-5-ethoxycarbonyl-6-cyano-1,4-dihydropyridine-3-carboxylic acid was obtained. Yellow crystals (450 female) (further recrystallized from diethyl ether and n-hexane yielded mp139-140
00) is obtained. ■ Example 4-{2
2-ethoxyshethyl ester of -methyl-4-(2nitrophenyl)-5-ethoxycarbonyl-6-formyl-1,4-dihydropyridine-3-carboxylic acid (90
2-methyl-4-(2-nitrophenyl)-5-ethoxycarbonyl from a mixture of sodium acetate (milk 1), hydroxylamine hydrochloride (9 of 167) and acetic acid (7) and acetic anhydride (1) -6-cyano 1・
Crystals of 2-ethoxy Z ethyl ester of 4-dihydropyridine-3-carboxylic acid (42 product 9) (recrystallized from diethyl ether and n-hexane, mp129.5-13
0.5qo) is obtained.
実施例 5
(11 2−メチル−4一(2−クロロフヱニル)一6
−ホルミルー1・4−ジヒドロピリジン−3・5ージカ
ルボン酸ジヱチルヱステル(1.5ののエタノール(3
0の‘)溶液に縄杵下で水素化ほう素ナトリウム(15
5のo)を加え室温で2時間縄拝する。Example 5 (11 2-methyl-4-(2-chlorophenyl)-6
- Formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (1.5 parts of ethanol (3 parts)
Sodium borohydride (15') solution under rope pestle
Add 5 o) and stir at room temperature for 2 hours.
反応液を希塩酸で酸性とし、溶媒を蟹去した後残澄に水
を加え酢酸エチルで2回抽出する。抽出液を水洗乾燥後
溶媒を減圧下で蟹去し、得られた赤色油状物質(1.3
525夕)をジェチルェーテルに溶解した後室温で放置
する。不溶物を炉別し、炉液を放置すると徐々に結晶が
析出する。これを炉取し、ジェチルェーテルとn−へキ
サンの混液から再結晶するとmp14y0の2−メチル
一4−(2−クロロフエニル)一6−ヒドロキシメチル
−1・4ージヒドロピリジンー3・5ージカルボン酸ジ
エチルェステルの結晶(92.0の9)を得る。‘2)
2ーメチルー4−(2ークロロフエニル)一6−アセ
チルー1・4−ジヒドロピリジン−3・5ージカルボン
酸ジメチルェステル(450の9)のメタノール(15
の【)溶液に氷冷燈梓下徐々に水素化ほう素ナトリウム
(46.軌9)を加え、氷袷下35分間燈拝する。The reaction solution was made acidic with dilute hydrochloric acid, the solvent was removed, water was added to the residue, and the mixture was extracted twice with ethyl acetate. After washing the extract with water and drying, the solvent was removed under reduced pressure to obtain a red oily substance (1.3
525) was dissolved in diethyl ether and then allowed to stand at room temperature. If the insoluble matter is separated in a furnace and the furnace liquid is left to stand, crystals will gradually precipitate. When this was taken in a furnace and recrystallized from a mixture of diethyl ether and n-hexane, diethyl 2-methyl-4-(2-chlorophenyl)-6-hydroxymethyl-1,4-dihydropyridine-3,5-dicarboxylate of mp14y0 was obtained. Obtain crystals of Stell (9 of 92.0). '2)
Methanol (15
Gradually add sodium borohydride (46.9) to the solution in [2] under an ice-cold lamp, and let the lamp stand under the ice for 35 minutes.
反応液を氷袷下が‐塩酸で中和し、減圧下水裕上で30
午0以下の温度で溶媒を蟹去する。残糟に水と少量の重
炭酸ナトリウム水溶液を加えてpH7−8に調整し、放
置すると白色粉末が得られる。これを炉取乾燥し得られ
た粉末(395.0雌)にジェチルェーテル(20泌)
を加え室温で30分間鍵拝する。析出する白色不溶物を
炉別し、ジェチルェーテルで洗浄する。洗液と炉液を合
し、比較的低温度で溶媒を蟹去するとmp145−14
7q0の2ーメチルー4一(2ークロロフエニル)一6
−(1−ヒドロキシエチル)−1・4−ジヒドロピリジ
ン−3・5−ジカルボン酸ジメチルェステルの結晶(1
00.5の夕)を得る。【3} 2ーメチルー4−(2
−ニトロフエニル)一6ーホルミルー1・4−ジヒドロ
ピリジン−3・5ージカルポン酸ジェチルェステル(2
.0881夕)のエタノール(29の‘)溶液に澄梓下
徐々に水素化ほう素ナトリウム(0.1892夕)を加
え、室温で1時間燈拝する。The reaction solution was neutralized with hydrochloric acid and heated under reduced pressure for 30 minutes.
The solvent is removed at a temperature below midnight. The residue is adjusted to pH 7-8 by adding water and a small amount of aqueous sodium bicarbonate solution, and upon standing, a white powder is obtained. This was dried in a furnace, and the resulting powder (395.0 female) was added to the powder (395.0 females) containing jethyl ether (20 secretions).
Add and incubate at room temperature for 30 minutes. The precipitated white insoluble matter is filtered out and washed with diethyl ether. When the washing liquid and furnace liquid are combined and the solvent is removed at a relatively low temperature, mp145-14
7q0 2-methyl-4-(2-chlorophenyl)-6
-(1-Hydroxyethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester crystals (1
00.5 evening). [3} 2-methyl-4-(2
-nitrophenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (2
.. Sodium borohydride (0.1892 mm) was gradually added to an ethanol (29') solution of 0.0881 mm) under clear water and allowed to stand at room temperature for 1 hour.
反応液を希塩酸で酸性とし30分間室温で燈拝した後炉
過する。白色不溶物(329.7mc)は炉別して、炉
液を減圧下で濃縮し酢酸エチルで抽出し、抽出液を水洗
乾燥後溶媒を留去する。得られた燈色油状物質(1.8
596夕)をエタノールに溶解し、不落物(337.7
雌)は炉別して、炉液を減圧下で濃縮し油状残澄を3日
間放置すると結晶が得られる。これをジェチルェーテル
から再結晶するとmpl12−11守○の2ーメチル−
4−(2ーニトロフエニル)一6−ヒドロキシメチル−
1・4ージヒドロピリジン−3・5ージカルボン酸ジェ
チルヱステルの結晶を得る。【4} 2ーメチルー4一
(3ーニトロフエニル)一6ーホルミル−1・4ージヒ
ドロピリジン−、3・5−ジカルボン酸ジェチルェステ
ル(233雌)のエタノール(10の‘)溶液に0一5
℃で縄梓下水秦化ほう素ナトリウム(22.7M)を加
え、0−5℃で1時間10分鷹拝する。The reaction solution was made acidic with dilute hydrochloric acid, heated for 30 minutes at room temperature, and then filtered. The white insoluble matter (329.7mc) was separated in a furnace, the furnace liquid was concentrated under reduced pressure and extracted with ethyl acetate, the extract was washed with water and dried, and the solvent was distilled off. The resulting light-colored oily substance (1.8
596 yen) was dissolved in ethanol, and the impregnable matter (337.7 yen) was dissolved in ethanol.
(female) is separated in a furnace, the furnace liquid is concentrated under reduced pressure, and the oily residue is left to stand for 3 days to obtain crystals. When this is recrystallized from diethyl ether, 2-methyl- of mpl12-11 Mori○ is obtained.
4-(2nitrophenyl)-6-hydroxymethyl-
Crystals of 1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester are obtained. [4} 2-Methyl-4-(3-nitrophenyl)-6-formyl-1,4-dihydropyridine-, 0-5 in an ethanol (10') solution of 3,5-dicarboxylic acid diethyl ester (233 female)
Add sodium borohydride (22.7M) to the suspension at 0-5°C for 1 hour and 10 minutes.
反応液を0.1N−塩酸で苗4−5に調整し、減圧下で
溶媒を留去する。残澄を酢酸エチルで抽出し抽出液を水
洗し硫酸マグネシウムで乾燥した後減圧下で濃縮する。
磯笹をジヱチルェーテルとnーヘキサンの混液で処理し
、得られた結晶をジェチルェーテルとnーヘキサンの混
液から再結晶するとmp141一142.5℃の2−メ
チル−4−(3−ニトロフエニル)−6ーヒドロキシメ
チル−1・4ージヒドロピリジンー3・5−ジカルポン
酸ジェチルェステルの結晶(152のc)を得る。‘5
’ 2−メチル−4一(2ートリフルオロメチルフエニ
ル)一6ーホルミル−1・4−ジヒドロピリジン−3・
5ージカルボン酸ジェチルェステル(1.0夕)のエタ
ノール(20の【)溶液に氷冷蝿洋下徐々に水素化ほう
素ナトリウム(滋のo)を加え、さらに25分間蝿拝す
る。The reaction solution was adjusted to the size of 4-5 seedlings with 0.1N hydrochloric acid, and the solvent was distilled off under reduced pressure. The residue is extracted with ethyl acetate, the extract is washed with water, dried over magnesium sulfate, and concentrated under reduced pressure.
When Isosasa is treated with a mixture of diethyl ether and n-hexane and the obtained crystals are recrystallized from a mixture of diethyl ether and n-hexane, 2-methyl-4-(3-nitrophenyl)-6-hydroxy with a temperature of mp141-142.5℃ is obtained. Crystals of methyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (152c) are obtained. '5
'2-Methyl-4-(2-trifluoromethylphenyl)-6-formyl-1,4-dihydropyridine-3.
To a solution of 5-dicarboxylic acid diethyl ester (1.0 ml) in ethanol (20 ml) under ice-cold water, gradually add sodium borohydride (Shinobu O) and stir for an additional 25 minutes.
反応液を0.1N−塩酸で斑4−5に調整し、減圧下比
較的低い温度で溶媒を蟹去する。残溝に水を加えて、得
られた結晶(1.2夕)を炉取し、ジェチルェーテルと
nーヘキサンの濠液から再結晶するとmp147一14
8.5こ○の2ーメチルー4−(2ートリフルオ。メチ
ルフエニル)一6ーヒドロキシメチルー1・4−ジヒド
ロピリジンー3・5ージカルボン酸ジェチルェステルの
結晶を得る。{6} 2−メチル一4一(3−ニトロフ
エニル)一5ーエトキシカルボニル−6−ホルミル−1
・4ージヒドロピリジンー3ーカルボン酸の2ーエトキ
シエチルエステル(1.132)のエタノール(15の
上)溶液に氷袷燈投下水素化ほう素ナトリウム(80奴
‘)を加え、氷袷下1時間蝿拝する。The reaction solution was adjusted to a speck of 4-5 with 0.1N hydrochloric acid, and the solvent was removed under reduced pressure at a relatively low temperature. Water was added to the remaining groove, the obtained crystals (1.2 hours) were collected in a furnace, and recrystallized from a solution of diethyl ether and n-hexane, resulting in mp147-14.
8.5 square crystals of 2-methyl-4-(2-trifluoromethylphenyl)-6-hydroxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester are obtained. {6} 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-formyl-1
・To a solution of 2-ethoxyethyl ester of 4-dihydropyridine-3-carboxylic acid (1.132) in ethanol (above 15) was added sodium borohydride (80 Ng) under ice for 1 hour. Worship flies.
反応液を氷冷下希塩酸でpH6にし、減圧下で溶媒を留
去する。残繕に水を加えジェチルェーテルで抽出し、抽
出液を水洗後硫酸マグネシウムで乾燥する。溶媒を蟹去
し、得られた油状物質をnーヘキサンで処理して結晶化
し、次いでジェチルェーテルとn−へキサンの混液から
再結晶するとmp99一100q0の2−メチル−4−
(3−ニトロフエニル)一5ーエトキシカルボニル−6
ーヒドロキシメチルー114ージヒドロピリジンー3−
カルボン酸の2−ェトキシェチルェステルの結晶(90
0倣)を得る。(71 2ーメチルー4一(3ーニトロ
フエニル)一5ーエトキシカルボニル一6ーホルミル−
1・4−ジヒドロピリジンー3ーカルボン酸の2−(N
−メチル−Nーベンジルアミノ)エチルヱステル(1.
5夕)のエタノール(15机)溶液に氷冷燈梓下水素化
ほう素ナトリウム(112の2)を加え、氷袷下20分
間縄拝する。The reaction solution was adjusted to pH 6 with diluted hydrochloric acid under ice cooling, and the solvent was distilled off under reduced pressure. Water is added to the residue, extracted with diethyl ether, and the extract is washed with water and dried over magnesium sulfate. The solvent was removed, and the resulting oil was crystallized by treatment with n-hexane, and then recrystallized from a mixture of diethyl ether and n-hexane to give 2-methyl-4- with mp99-100q0.
(3-nitrophenyl)-5-ethoxycarbonyl-6
-Hydroxymethyl-114-dihydropyridine-3-
Crystals of 2-ethoxychetyl ester of carboxylic acid (90
0 copies). (71 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-formyl-
2-(N of 1,4-dihydropyridine-3-carboxylic acid
-Methyl-N-benzylamino)ethyl ester (1.
Sodium borohydride (112-2) was added to the ethanol (15 liters) solution of 20 minutes under ice and soaked under ice for 20 minutes.
反応液を氷冷下0.1N−塩酸で柵6−7にし、減圧下
で濃縮する。残澄に水と酢酸エチルを加え、水溶液をさ
らに酢酸エチルで2回洗浄する。抽出液と洗液を合し、
水洗後硫酸マグネシウムで乾燥し、減圧下で溶媒を蟹去
すると油状の2ーメチル−4一(3−ニトロフエニル)
−5−エトキシカルポニルー6ーヒドロキシメチルー1
14ージヒドロピリジン−3ーカルボン酸の2一(N−
メチル一Nーベンジルアミノ)エチルエステル(1.4
8夕)を得る。赤外線吸収スペクトル(フィルム)
3390、1730、1680、1650、1600、
1520、14601345、1200、1100、1
025、900、780、?40700伽‐1核磁気共
鳴吸収スペクトル(6、CDC13十D20)1.2(
斑、t、Ji7HZ)、2.2(細、s)、2.38(
3日、s)、2.66(2日、t、J=6HZ)、3,
53(が、s)「 3.97‐4,26(4日、m)、
5.14(IH、s〉、7.28‐815(1皿、m)
上記で得られた油状物質をジェチルェーテルに溶解し、
21%エタノール性塩酸(225の9)を加える。The reaction solution was covered with 0.1N hydrochloric acid under ice cooling and concentrated under reduced pressure. Water and ethyl acetate are added to the residue, and the aqueous solution is further washed twice with ethyl acetate. Combine the extract and washing liquid,
After washing with water and drying with magnesium sulfate, the solvent was removed under reduced pressure to obtain oily 2-methyl-4-(3-nitrophenyl).
-5-ethoxycarponyl-6-hydroxymethyl-1
2-(N-) of 14-dihydropyridine-3-carboxylic acid
Methyl-N-benzylamino)ethyl ester (1.4
8 evenings). Infrared absorption spectrum (film) 3390, 1730, 1680, 1650, 1600,
1520, 14601345, 1200, 1100, 1
025, 900, 780,? 40700 Ka-1 nuclear magnetic resonance absorption spectrum (6, CDC130D20) 1.2 (
Spot, t, Ji7HZ), 2.2 (thin, s), 2.38 (
3 days, s), 2.66 (2 days, t, J=6HZ), 3,
53 (ga, s) "3.97-4,26 (4th, m),
5.14 (IH, s), 7.28-815 (1 plate, m)
Dissolve the oily substance obtained above in diethyl ether,
Add 21% ethanolic hydrochloric acid (9 of 225).
析出する油状物質を優しや法によりジェチルェーテルで
数回洗浄し粉末化すると2ーメチルー4−(3ーニトロ
フエニル)−5ーエトキシカルボニル−6ーヒドロキシ
メチル−114ージヒドロピリジン−3ーカルボン酸の
2一(NーメチルーNーベンジルアミノ)エチルェステ
ルの塩酸塩を得る。このものは8ぴ0で分解し始め褐色
に変る。実施例 6
{112ーメチル−4一(2−クロロフエニル)一6−
ヒドロキシメチル−114ージヒドロピリジン−305
ージカルボン酸ジェチルェステル(759.7のo)の
乾燥ピリジン溶液に氷冷摺梓下酢酸クロラィド(313
.5の9)の塩化メチレン溶液を滴下し、室温で一夜縄
拝する。The precipitated oily substance is washed several times with diethyl ether and powdered using the gentle method, resulting in 2-(N-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-hydroxymethyl-114-dihydropyridine-3-carboxylic acid). The hydrochloride of N-benzylamino)ethyl ester is obtained. This stuff starts to decompose at 8pm and turns brown. Example 6 {112-methyl-4-(2-chlorophenyl)-6-
Hydroxymethyl-114-dihydropyridine-305
A dry pyridine solution of dicarboxylic acid diethyl ester (759.7 o) was added with acetic acid chloride (313 o) under an ice-cooled slurry.
.. Add the methylene chloride solution of 5-9) dropwise, and leave at room temperature overnight.
溶媒を留去し「残笹に水を加えて、希塩酸で弱酸性とし
た後ジェチルェーテルで抽出する。抽出液を塩化ナトリ
ウム飽和水溶液、次いで水で洗浄し、乾燥した後溶媒を
蟹去する。得られた粘鋼性油状物質は放置すると結晶化
し、これをn−へキサンで洗浄して、得られた結晶(0
.6931夕)をジェチルェーテルとn−へキサンの混
液から再結晶するとmp98qoの2ーメチル−4一(
2ークロロフエニル)−6ーアセトキシメチルー114
−ジヒドロピリジン−3・5ージカルボン酸ジェチルェ
ステルの結晶を得る。■ 3−(NーメチルーN−ペン
ジルアミノ)プロピオン酸ナトリウム塩(2.0夕)と
ジエチルェーテル(40の【)の混合物に氷冷燈洋下チ
オニルクロライド(10の【)を加え、室温で3時間縄
拝し、2時間加熱還流した後、減圧下で濃縮する。The solvent is distilled off, water is added to the remaining bamboo, made weakly acidic with dilute hydrochloric acid, and then extracted with diethyl ether. The extract is washed with a saturated aqueous sodium chloride solution and then with water, dried, and the solvent is removed. The resulting viscous oily substance crystallizes when left to stand, and is washed with n-hexane to give the resulting crystals (0
.. Recrystallization of 2-methyl-41 of mp98qo from a mixture of diethyl ether and n-hexane
2-chlorophenyl)-6-acetoxymethyl-114
-Dihydropyridine-3,5-dicarboxylic acid diethyl ester crystals are obtained. ■ To a mixture of 3-(N-methyl-N-pendylamino)propionate sodium salt (2.0 minutes) and diethyl ether (40 minutes) was added thionyl chloride (10 points) under an ice-cold lamp, and the mixture was stirred at room temperature for 3 hours. After heating and refluxing for 2 hours, the mixture is concentrated under reduced pressure.
得られた3一(N−メチル一Nーベンジルアミノ)プロ
ピオン酸クロライドの塩化メチレン(5の‘)懸濁液を
2−メチル一4一(2−クロロフエニル)一6ーヒドロ
キシメチルー1・4ージヒドロピリジンー3・5ージカ
ルボン酸ジエチルヱステル(0.76夕)をピリジン(
5の【)溶液に氷冷縄杵下に加え、氷袷下1時間縄拝す
る。減圧下で溶媒を蟹去し、残澄に水を加えて酢酸エチ
ルで抽出する。抽出液を水で洗浄し、乾燥した後溶媒を
留去する。得られた褐色油状物質(1.55のを溶出溶
媒(ベンゼン:酢酸エチル;2:1)を用いてシリカゲ
ルカラムクロマトグラフイーに付して、得られた油状物
質を一夜放置すると結晶が得られる。これをn−へキサ
ンで洗浄し、ジェチルェーテルとn−へキサンの混液か
ら再結晶するとmp86−87℃の2−メチル一4一(
2ークロロフエニル)−6一〔3−(Nーメチル−Nー
ベンジルアミノ)プロピオニルオキシメチル〕一1・4
−ジヒドロピリジン−3・5ージカルボン酸ジェチルェ
ステルの結晶を得る。【3} 2ーメチル−4−(2ー
ニトロフエニル)一6−ヒドロキシメチル−1・4ージ
ヒドロピリジンー3・5−ジカルボン酸ジヱチルェステ
ル(2.352)のピリジン(30の【)溶液に氷冷擬
梓下7分を要して酢酸クロラィド(942の2)の塩化
メチレン(5の【)溶液を滴下し、室温で70分間燈拝
する。The resulting suspension of 3-(N-methyl-N-benzylamino)propionic acid chloride in methylene chloride (5') was added to 2-methyl-4-(2-chlorophenyl)-6-hydroxymethyl-1,4-dihydropyridine. -3,5-dicarboxylic acid diethyl ester (0.76 m) was dissolved in pyridine (
Add to the solution in step 5 () under an ice-cold rope pestle and keep the rope under ice for 1 hour. The solvent was removed under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract is washed with water, dried, and then the solvent is distilled off. The obtained brown oil (1.55%) was subjected to silica gel column chromatography using an eluent (benzene: ethyl acetate; 2:1), and the obtained oil was left overnight to obtain crystals. This was washed with n-hexane and recrystallized from a mixture of diethyl ether and n-hexane to give 2-methyl-41 (mp 86-87°C).
2-chlorophenyl)-6-[3-(N-methyl-N-benzylamino)propionyloxymethyl]-1,4
-Dihydropyridine-3,5-dicarboxylic acid diethyl ester crystals are obtained. [3} 2-Methyl-4-(2nitrophenyl)-6-hydroxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (2.352) in a solution of pyridine (30) under ice-cooling. Over a period of 7 minutes, a solution of acetic acid chloride (942-2) in methylene chloride (5) was added dropwise, and the mixture was allowed to stand at room temperature for 70 minutes.
減圧下溶媒を留去し、残澄に酢酸エチルを加え、2回水
洗後塩酸で柑4とした後塩化ナトリウム水溶液で洗浄し
、乾燥する。減圧下で溶媒を蟹去して、得られた油状物
質をジェチルェーテルと少量のnーヘキサンの濠液で処
理して結晶化する。次いで炉取した結晶(2.5夕)を
n−へキサンで洗浄し、ジェチルェーテルから再結晶す
るとmp89一90COの2−メチル−4一(2ーニト
ロフエニル)一6−アセトキシメチル−1・4−ジヒド
ロピリジンー3・5ージカルボン酸ジェチルェステルの
結晶(1.78夕)を得る。The solvent was evaporated under reduced pressure, ethyl acetate was added to the residue, and the residue was washed twice with water, washed with hydrochloric acid, washed with an aqueous sodium chloride solution, and dried. The solvent is removed under reduced pressure and the resulting oil is crystallized by treatment with a solution of diethyl ether and a small amount of n-hexane. Next, the crystals collected in the furnace (2.5 nights) were washed with n-hexane and recrystallized from diethyl ether to yield 2-methyl-4-(2-nitrophenyl)-6-acetoxymethyl-1,4-dihydropyridine with mp89-90CO. -3,5-dicarboxylic acid diethyl ester crystals (1.78 min.) were obtained.
(41 2ーメチルー4一(3ーニトロフエニル)−6
−ヒドロキシメチルー1・4−ジヒドロピリジンー3・
5ージカルボン酸ジェチルヱステル(1.95のの乾燥
ピリジン(25羽)溶液に氷冷蝿梓下IQ分間を要して
、酢酸クロラィド(785奴)の塩化メチレン(5叫)
溶液を滴下し、室温で50分間燈梓する。(41 2-methyl-4-(3nitrophenyl)-6
-Hydroxymethyl-1,4-dihydropyridine-3.
A solution of 5-dicarboxylic acid diethylester (1.95 μm) in dry pyridine (25 μm) was added to a solution of acetic acid chloride (785 μm) in methylene chloride (5 μm) under ice-cold water.
Add the solution dropwise and let stand at room temperature for 50 minutes.
溶媒を蟹去し、残燈を酢酸エチルに溶解し、水で5回次
いで塩化ナトリウム水溶液で洗浄した後硫酸マグネシウ
ムで乾燥する。溶媒を留去して、得られた赤色油状物質
(2.47夕)をジェチルェーテルで処理して結晶化し
、n−へキサンで洗浄した後結晶(2夕)を炉取する。
これをジェチルェーテルに溶解し、シリカゲルで炉遇し
た後、炉液を減圧下で濃縮する。結晶性残笹をジェチル
ェーテルとnーヘキサンの濠液から再結晶するとmp1
33−1360の2−メチル−4一(3−ニトロフエニ
ル)一6−アセトキシメチルー1・4−ジヒドロピリジ
ンー3・5−ジカルボン酸ジェチルェステルの結晶(1
.45夕)を得る。【5) 2ーメチルー4一(3ーニ
トロフエニル)一5ーエトキシカルボニル−6ーヒドロ
キシメチル−1・4ージヒドロピリジンー3ーカルボン
酸の2−(N−メチル−Nーベンジンアミノ)エチルエ
ステル(630M)のピリジン(10の【)溶液に氷冷
蝿梓下酢酸クロラィド(146の9)の塩化メチレン(
3の‘)溶液を加え、50一60ooで2時間蝿辞する
。The solvent is removed, and the residual light is dissolved in ethyl acetate, washed five times with water and then with an aqueous sodium chloride solution, and then dried over magnesium sulfate. The solvent was distilled off, and the resulting red oil (2.47 nights) was crystallized by treatment with diethyl ether, washed with n-hexane, and the crystals (2 nights) were collected in a furnace.
This is dissolved in diethyl ether, treated with silica gel, and the solution is concentrated under reduced pressure. When the crystalline residue is recrystallized from a solution of diethyl ether and n-hexane, mp1 is obtained.
Crystals of 2-methyl-4-(3-nitrophenyl)-6-acetoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester of 33-1360 (1
.. 45 evenings). [5] Pyridine of 2-(N-methyl-N-benziamino)ethyl ester (630M) of 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-hydroxymethyl-1,4-dihydropyridine-3-carboxylic acid (630M) Add acetic acid chloride (9 of 146) to methylene chloride (9 of 146) in ice-cooled solution of [10].
Add the solution of step 3) and incubate at 50-60°C for 2 hours.
溶媒を留去し、残鷹に水と酢酸エチルを加え、次いで水
層をpH4に調整する。有機層を分離し、硫酸マグネシ
ウムで乾燥した後、減圧下で濃縮する。得られた油状物
質(800のo)を溶出溶媒(ベンゼン:酢酸エチル=
2:1)を用いてシリカゲルカラムクロマトグラフィー
に付して精製すると油状の2−メチル一4一(3−ニト
ロフヱニル)一5ーエトキシカルボニル一6ーアセトキ
シメチル−1・4−ジヒドロピリジンー3−カルボン酸
の2一(N−メチル−Nーベンジルアミノ)エチルエス
テル(620の9)を得る。赤外線吸収スペクトル(フ
ィルム)
3370、1747、1690、1650、1615、
1530、14801350121リ1100、104
ふ 740、700仇核磁気共鳴吸収スペクトル(6、
CDC13十D20)1.18(3日、t、J =7H
Z)、2.18(細、s)、2.36(細、s)、2.
6(餌、t、J:6HZ)、3.5(が、s)、4.0
6(餌、q、J!7HZ)、4.15(2日、t、J
=6HZ)、5.13(IH、s)、5.31(が、s
)、6.7(IH、m)、7.23‐8,08(餌、m
)上記で得られた油状物質(580柵)をジェチルェー
テルに溶解した溶液にマレィン酸のジェチルェーテル溶
液を徐々に加え、析出する油状物質を分離して、領しや
法によりジェチルェーテルで2回洗浄した後n−へキサ
ンで粉末化するとmp班一65℃の2−メチル一4一(
3ーニトロフエニル)−5ーヱトキシカルボニル−6−
アセトキシメチル−1・4ージヒドロピリジンー3ーカ
ルポン酸の2一(N−メチル−N−ペンジルアミノ)エ
チルェステルのマレイン酸塩の粉末(405M)を得る
。The solvent was distilled off, water and ethyl acetate were added to the residue, and the aqueous layer was then adjusted to pH 4. The organic layer is separated, dried over magnesium sulfate, and then concentrated under reduced pressure. The obtained oily substance (800 o) was dissolved in an elution solvent (benzene:ethyl acetate=
When purified by silica gel column chromatography using 2:1), an oily 2-methyl-41(3-nitrophenyl)-5-ethoxycarbonyl-6-acetoxymethyl-1,4-dihydropyridine-3-carbonyl was obtained. The 2-(N-methyl-N-benzylamino)ethyl ester (9 of 620) of the acid is obtained. Infrared absorption spectrum (film) 3370, 1747, 1690, 1650, 1615,
1530, 14801350121 1100, 104
Fu 740, 700Nuclear magnetic resonance absorption spectrum (6,
CDC130D20) 1.18 (3 days, t, J = 7H
Z), 2.18 (thin, s), 2.36 (thin, s), 2.
6 (bait, t, J: 6HZ), 3.5 (ga, s), 4.0
6 (bait, q, J!7HZ), 4.15 (2 days, t, J
=6HZ), 5.13 (IH, s), 5.31 (but, s
), 6.7 (IH, m), 7.23-8,08 (bait, m
) A solution of maleic acid in diethyl ether was gradually added to a solution of the oily substance obtained above (580 bars) dissolved in diethyl ether, and the precipitated oily substance was separated and washed twice with diethyl ether using the Rishiya method. When powdered with n-hexane, 2-methyl-41 (
3-nitrophenyl)-5-ethoxycarbonyl-6-
A powder (405M) of maleate of 2-(N-methyl-N-pendylamino)ethyl ester of acetoxymethyl-1,4-dihydropyridine-3-carboxylic acid is obtained.
(6) 2ーメチルー4一(2ーニトロフエニル)一6
−ヒドロキシメチルー1・4−ジヒドロピリジンー3・
5−ジカルボン酸ジェチルェステル(1.95夕)のピ
リジン(25の【)溶液に氷袷蝿梓下Pークロロフェノ
キシ酢酸クロライド(3.07夕)の塩化メチレン溶液
を5分間を要して滴下し、水で2び0に冷却して一夜燈
梓する。溶媒を蟹去し「磯鷹に水を加え、酢酸エチルで
抽出する。抽出液を希塩酸でpH4一5とした後水で3
回次いで重炭酸ナトリウム水溶液で洗浄し、乾燥した後
溶媒を蟹去する。得られた油状物質(4.75夕)を溶
出溶媒(ベンゼン:酢酸エチル=10三1)を用いてシ
リカゲルカラムクロマトグラフィーに付して精製すると
油状の2−メチル−4一(2ーニトロフエニル)一6−
(4−クロロフエノキシ)アセトキシメチル−1・4−
ジヒドロピリジン−3・5−ジカルポン酸ジェチルェス
テル(2.65夕)を得る。これは冷所に放置すると結
晶化しジィソプロピルェーテルとエタノールの混液から
再結晶するとmp86一8が0の黄色粒状晶を得る。核
磁気共鳴吸収スペクトル(8、CDC13十020>1
.13(紐、t、J=7HZ)、2.2(斑、s)、4
.03、4.08(4日、q、J=7Hz)、4・73
(2日、s)、5.43(2日、s)「 5.織(IH
、s)、6.53(IH、broad s)、6.76
−7.83(斑、m)実施例 7
‘1ー 2−アリルオキシベンズアルデヒド(811夕
)、4・4ージヱトキシアセト酢酸エチルェステル(1
2.00夕)およびベンゼン(約3机上)の混合物に酢
酸(0.36夕)を加え、次いで20分間豚でピベリジ
ン(0.51夕)のベンゼン(約4の‘)溶液を3回に
分けて加えた後2.5時間加熱還流する。(6) 2-methyl-4-(2-nitrophenyl)-6
-Hydroxymethyl-1,4-dihydropyridine-3.
A methylene chloride solution of P-chlorophenoxyacetic acid chloride (3.07 yen) was added dropwise to a solution of pyridine (25) of 5-dicarboxylic acid diethyl ester (1.95 yen) over 5 minutes. , cool to 2-0 with water and soak overnight. Remove the solvent, add water to Isotaka, and extract with ethyl acetate. Adjust the extract to pH 4-5 with diluted hydrochloric acid, and then add 30% with water.
It is then washed twice with aqueous sodium bicarbonate solution, dried and the solvent is removed. The obtained oily substance (4.75 minutes) was purified by silica gel column chromatography using an eluent (benzene:ethyl acetate=1031) to give an oily 2-methyl-41(2nitrophenyl)1. 6-
(4-chlorophenoxy)acetoxymethyl-1,4-
Dihydropyridine-3,5-dicarboxylic acid diethyl ester (2.65 hours) is obtained. This crystallizes when left in a cold place, and when recrystallized from a mixture of diisopropyl ether and ethanol, yellow granular crystals with mp86-8 of 0 are obtained. Nuclear magnetic resonance absorption spectrum (8, CDC13020>1
.. 13 (string, t, J=7HZ), 2.2 (spot, s), 4
.. 03, 4.08 (4th, q, J=7Hz), 4.73
(2nd, s), 5.43 (2nd, s) "5. Ori (IH
, s), 6.53 (IH, broad s), 6.76
-7.83 (spots, m) Example 7 '1-2-Allyloxybenzaldehyde (811), 4,4-ditoxyacetoacetic acid ethyl ester (1
Add acetic acid (0.36 mm) to a mixture of 2.00 mm) and benzene (approx. After adding in portions, the mixture was heated under reflux for 2.5 hours.
反応液を室温まで下げ、ベンゼン(50の‘)を加えた
後水洗3回行ない硫酸マグネシウムで乾燥する。溶媒を
留去し、赤色油状残溝に3ーァミノクロトン酸エチルヱ
ステル(8.56夕)を加え、55一60℃で6.曲時
間、次いで72−75℃で2時間さらに105−107
0で2.虫時間燈洋する。The reaction solution was cooled to room temperature, benzene (50%) was added thereto, washed with water three times, and dried over magnesium sulfate. The solvent was distilled off, and 3-aminocrotonate ethyl ester (8.56 pm) was added to the red oily residue, and the mixture was heated at 55-60°C for 6. 105-107 for an additional 2 hours at 72-75°C.
0 and 2. Insect Time Toyo.
反応液を溶出溶媒(塩化メチレン:アセトン=25:1
)を用いてシリカゲルカラムクロマトグラフィ−に付す
と油状物質(19.38夕)を得る。その一部(3.0
夕)をさらに溶出溶媒(ベンゼン:酢酸エチル=20:
1)を用いてシリカゲルカラムクロマトグラフィーに付
して精製すると油状の2−メチル−4一(2一アリルオ
キシフエニル)−6−ジエトキシメチルー1・4−ジヒ
ドロピリジンー3・5−ジカルボン酸ジェチルェステル
(1.7W)を得る。赤外線吸収スペクトル(IJキッ
ド)3430、1695、1650、1618、149
0、1371、128以1095930760伽‐1核
磁気共鳴吸収スペクトル(8、CDCWI.0‐1.5
(1が、m)、2.28(斑、s)、3.4‐4.3(
知日、m)、5.35(IH、s)、6.17(IH、
s)、4.ふ 5‐5.05.7−6.4(班、m)、
6.5‐7.4(斑、m)t2) 2ーメチルー4−(
2ーアリルオキシフエニル)一6−ジエトキシメチル−
1・4−ジヒドロピリジンー3・5ージカルポン酸ジェ
チルェステル(1.5夕)のアセトン(15の‘)溶液
に蝿投下で鮒−塩酸(1.5私)を加え、室温で1時間
48分櫨拝する。The reaction solution was dissolved in an elution solvent (methylene chloride: acetone = 25:1
) to obtain an oily substance (19.38 pm). Part of it (3.0
Further, the elution solvent (benzene: ethyl acetate = 20:
Purification by silica gel column chromatography using 1) yields oily 2-methyl-4-(2-allyloxyphenyl)-6-diethoxymethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. Obtain Jetilester (1.7W). Infrared absorption spectrum (IJ Kid) 3430, 1695, 1650, 1618, 149
0, 1371, 128 and above 1095930760 Ka-1 nuclear magnetic resonance absorption spectrum (8, CDCWI.0-1.5
(1 is m), 2.28 (spot, s), 3.4-4.3 (
Chihito, m), 5.35 (IH, s), 6.17 (IH,
s), 4. Fu 5-5.05.7-6.4 (group, m),
6.5-7.4 (spot, m) t2) 2-methyl-4-(
2-allyloxyphenyl)-6-diethoxymethyl-
To a solution of 1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (1.5 min) in acetone (15 min), carp-hydrochloric acid (1.5 min) was added by dropping a fly, and the mixture was incubated at room temperature for 1 hour and 48 minutes. do.
溶媒を留去し、孫総に水を加えると油状物質が析出した
黄色懸濁液が得られ、この油状物質は直ちに固化する。
これを10分間放置し、固形物を炉取した後水洗乾燥し
、ジィソプロピルェーテルとアセトンの混液から再結晶
するとmp129一13100の2ーメチルー4一(2
一アリルオキシフエニル)−6ーホルミルー1・4−ジ
ヒドロピリジンー3・5ージカルボン酸のジェチルェス
テルの燈黄色粒状晶を得る。【31 2−メチル−4−
(2−アリルオキシフエニル)−6−ホルミルー1・4
−ジヒドロピリジン−3・5ージカルボン酸ジヱチルェ
ステル(4.53夕)、ヒドロキシルアミン塩酸塩(8
66.9の9)、酢酸ナトリウム(1.2093夕)お
よび酢酸の混合物を室温で1時間蝿拝する。When the solvent is distilled off and water is added to the solenoid, a yellow suspension with an oily substance precipitated out is obtained, and this oily substance immediately solidifies.
This was left to stand for 10 minutes, the solid matter was taken out in an oven, washed with water, dried, and recrystallized from a mixture of diisopropyl ether and acetone.
Light yellow granular crystals of diethyl ester of monoallyloxyphenyl)-6-formyl-1,4-dihydropyridine-3,5-dicarboxylic acid are obtained. [31 2-methyl-4-
(2-allyloxyphenyl)-6-formyl-1,4
-Dihydropyridine-3,5-dicarboxylic acid diethyl ester (4.53 evening), hydroxylamine hydrochloride (8
A mixture of 66.9 of 9), sodium acetate (1.2093 m) and acetic acid is stirred at room temperature for 1 hour.
これに無水酢酸(3.5凧【)を加え93一9ぼ○で3
時間縄拝する。減圧下で酢酸を留去した後残簿を重炭酸
ナトリウム水溶液で中和し、塩化メチレンで2回抽出す
る。抽出液を2回水洗後乾燥する。溶媒を留去し、得ら
れた褐色油状残簿はたゞちに結晶化する。これをジイソ
ブロピルェーテルで粉末化して黄色粉末(3.21夕)
を得、90%メタ/−ノレから再結晶するとmp143
一1490の2−メチル一4−(2一アリルオキシフエ
ニル)−6−シアノー1・4ージヒドロピリジン−3・
5ージカルボン酸ジヱチルェステルの燈黄色結晶を得る
。{41 2ーメチル−4−(2ーアリルオキシフエニ
ル)−6ーホルミル−1・4ージヒドロピリジンー3・
5ージカルボン酸ジェチルェステル(4.70夕)のエ
タノール(100泌)溶液に4℃にて磯梓下徐々に水素
化ほう素ナトリウム(4452雌)を加え、氷冷下4℃
で1.5時間縄拝する。Add acetic anhydride (3.5 kites) to this and make 3
Worship for hours. After distilling off the acetic acid under reduced pressure, the residue is neutralized with aqueous sodium bicarbonate solution and extracted twice with methylene chloride. The extract is washed twice with water and then dried. The solvent is distilled off and the resulting brown oily residue immediately crystallizes. This was powdered with diisopropylether and turned into a yellow powder (3.21 evening).
When recrystallized from 90% meta/-nore, mp143 was obtained.
-1490-2-methyl-4-(2-allyloxyphenyl)-6-cyano1,4-dihydropyridine-3.
Light yellow crystals of 5-dicarboxylic acid diethyl ester are obtained. {41 2-methyl-4-(2-allyloxyphenyl)-6-formyl-1,4-dihydropyridine-3.
Sodium borohydride (4452 female) was gradually added to a solution of 5-dicarboxylic acid diethyl ester (4.70 ml) in ethanol (100 ml) at 4°C under ice-cooling at 4°C.
1.5 hours of rope worship.
反応液を50%酢酸で酸性とし、エタノールを留去した
後残隆に水を加え、10分間燈群する。析出する粉末を
炉取し、水洗して結晶(4.49夕)を得、これをメタ
ノールから再結晶するとmp124一12がoの2ーメ
チルー4一(2一アリルオキシフエニル)一6−ヒドロ
キシメチル−1・4ージヒドロピリジン−3・5ージカ
ルボン酸ジェチルェステルの黄色結晶を得る。The reaction solution was made acidic with 50% acetic acid, ethanol was distilled off, water was added to the residue, and the mixture was heated for 10 minutes. The precipitated powder was collected in a furnace and washed with water to obtain crystals (4.49 yen), which were recrystallized from methanol to yield 2-methyl-4-(2-allyloxyphenyl)-6-hydroxy with mp124-12 of o. Yellow crystals of methyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester are obtained.
Claims (1)
フルオロメチルおよびアルケニルオキシからなる群から
選ばれた基を有するフエニル基を、R_2およびR_3
は同一または異なるアルコキシカルボニル基、アルコキ
シアルコキシカルボニル基、アラルコキシアルコキシカ
ルボニル基またはN−アルキル−N−アラルキルアミノ
アルコキシカルボニル基を、R_4はシアノ基またはヒ
ドロキシ、非置換低級アルカノイルオキシ、低級アルコ
キシイミノ、オキソ、N−アルキル−N−アラルキルア
ミノ低級アルカノイルオキシもしくはモノハロアリール
オキシ低級アルカノイルオキシで置換されたアルキル基
を、R_5はアルキル基をそれぞれ意味する)で示され
る1・4−ジヒドロピリジン誘導体を含有することを特
徴とする血管拡張剤および血圧降下剤。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. , R_2 and R_3
are the same or different alkoxycarbonyl group, alkoxyalkoxycarbonyl group, aralkoxyalkoxycarbonyl group or N-alkyl-N-aralkylaminoalkoxycarbonyl group, R_4 is a cyano group or hydroxy, unsubstituted lower alkanoyloxy, lower alkoxyimino, Contains a 1,4-dihydropyridine derivative represented by an alkyl group substituted with oxo, N-alkyl-N-aralkylamino lower alkanoyloxy or monohaloaryloxy lower alkanoyloxy, and R_5 means an alkyl group, respectively. A vasodilator and antihypertensive agent.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27945/1975 | 1975-07-02 | ||
| GB27945/75A GB1552911A (en) | 1975-07-02 | 1975-07-02 | 1,4 dihydropyridine derivatives and the preparation thereof |
| GB39854/1975 | 1975-09-29 | ||
| GB51524/1976 | 1975-12-16 | ||
| GB13761/1976 | 1976-04-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51079413A Division JPS5948827B2 (en) | 1975-07-02 | 1976-07-02 | 1,4-dihydropyridine derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59231017A JPS59231017A (en) | 1984-12-25 |
| JPS6012324B2 true JPS6012324B2 (en) | 1985-04-01 |
Family
ID=10267810
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59091232A Granted JPS601154A (en) | 1975-07-02 | 1984-05-07 | Intermediate of 1,4-dihydropyridine derivative |
| JP59091231A Expired JPS6012324B2 (en) | 1975-07-02 | 1984-05-07 | Vasodilators and antihypertensive agents containing 1,4-dihydropyridine derivatives |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59091232A Granted JPS601154A (en) | 1975-07-02 | 1984-05-07 | Intermediate of 1,4-dihydropyridine derivative |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS601154A (en) |
| ZA (1) | ZA763955B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0616661Y2 (en) * | 1988-07-28 | 1994-05-02 | 兼松デュオファスト株式会社 | Piston / cylinder device for feeding mechanism of fastener driving machine |
| US6334424B1 (en) * | 1999-03-05 | 2002-01-01 | Toyota Jidosha Kabushiki Kaisha | Control device and control method for vehicle |
-
1976
- 1976-07-02 ZA ZA763955A patent/ZA763955B/en unknown
-
1984
- 1984-05-07 JP JP59091232A patent/JPS601154A/en active Granted
- 1984-05-07 JP JP59091231A patent/JPS6012324B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS601154A (en) | 1985-01-07 |
| ZA763955B (en) | 1977-10-26 |
| JPS59231017A (en) | 1984-12-25 |
| JPS619300B2 (en) | 1986-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4145432A (en) | 6-acyloryalkyl-1,4-dihydropyridine derivatives and a method of effecting vasodilation therewith | |
| US4572909A (en) | 2-(Secondary aminoalkoxymethyl) dihydropyridine derivatives as anti-ischaemic and antihypertensive agents | |
| US4430333A (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| US4988717A (en) | Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses | |
| US4338322A (en) | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same | |
| US4284634A (en) | 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same | |
| JPS6341903B2 (en) | ||
| FI66368C (en) | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC ANVAENDBARA 6,1-DIHYDRO-11-OXODIBENS (B E) OXEPIN-2-ACETIC XRIDERATIVES | |
| US4851409A (en) | 2-substituted quinoline dioic acids and pharmaceutical compositions | |
| JPH10510513A (en) | New benzoxazoles | |
| JPS6125711B2 (en) | ||
| HU176454B (en) | Process for preparing 1,4-dihydro-pyridine derivatives | |
| KR20000064682A (en) | Benzopyran derivatives with leukotriene-antagonistic activity | |
| US4806534A (en) | Therapeutically active flavonyl-1,4-dihydrophyridines | |
| US4678786A (en) | Pharmaceutical compositions having β-adrenoceptor antagonist activity employing pyridazinone derivatives | |
| US4370334A (en) | 1,4-Dihydro-pyridine derivatives and methods of using same | |
| US4021434A (en) | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate | |
| US5017586A (en) | 5-dialkylaminomethyl-2-furanomethanol derivatives having anti-hypertensive properties | |
| US5225558A (en) | 2-amino-5-cyano-1,4-dihydropyridines, and their use in medicaments | |
| SU1083909A3 (en) | Process for preparing 6-substituted derivatives of pyranone | |
| US5204472A (en) | Quinoline and isoquinoline intermediates | |
| JPS6012324B2 (en) | Vasodilators and antihypertensive agents containing 1,4-dihydropyridine derivatives | |
| US4495192A (en) | 1-Substituted 1,4-dihydropyridines | |
| JPS6270359A (en) | 2-substituted-1,4-dihydropyridine, manufacture and medicinal composition | |
| US4898865A (en) | [4-(6-Oxo-1,4,5,6-tetrahydro-3-pyridazinyl) anilino hexyl 1,4-dihydro-2,6 Di methyl 5 nitro 4 aryl pyridine 3-carboxylates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term | ||
| LAPS | Cancellation because of no payment of annual fees |